101
|
Estrada H, Ozbek A, Robin J, Shoham S, Razansky D. Spherical Array System for High-Precision Transcranial Ultrasound Stimulation and Optoacoustic Imaging in Rodents. IEEE TRANSACTIONS ON ULTRASONICS, FERROELECTRICS, AND FREQUENCY CONTROL 2021; 68:107-115. [PMID: 32406833 PMCID: PMC7952015 DOI: 10.1109/tuffc.2020.2994877] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/08/2023]
Abstract
Ultrasound can be delivered transcranially to ablate brain tissue, open the blood-brain barrier, or affect neural activity. Transcranial focused ultrasound in small rodents is typically done with low-frequency single-element transducers, which results in unspecific targeting and impedes the concurrent use of fast neuroimaging methods. In this article, we devised a wide-angle spherical array bidirectional interface for high-resolution parallelized optoacoustic imaging and transcranial ultrasound (POTUS) delivery in the same target regions. The system operates between 3 and 9 MHz, allowing to generate and steer focal spots with widths down to [Formula: see text] across a field of view covering the entire mouse brain, while the same array is used to capture high-resolution 3-D optoacoustic data in real time. We showcase the system's versatile beam-forming capacities as well as volumetric optoacoustic imaging capabilities and discuss its potential to noninvasively monitor brain activity and various effects of ultrasound emission.
Collapse
|
102
|
Mohamed AA, Alawna M. The use of passive cable theory to increase the threshold of nociceptors in people with chronic pain. PHYSICAL THERAPY REVIEWS 2020. [DOI: 10.1080/10833196.2020.1853493] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Affiliation(s)
- Ayman A. Mohamed
- Department of Physiotherapy, Faculty of Health Sciences, Istanbul Gelisim University, Turkey
| | - Motaz Alawna
- Department of Physiotherapy, Faculty of Health Sciences, Istanbul Gelisim University, Turkey
- Department of Physiotherapy and Rehabilitation, Faculty of Allied Medical Sciences, Arab American University, Jenin, Palestin
| |
Collapse
|
103
|
Liput DJ, Nguyen TA, Augustin SM, Lee JO, Vogel SS. A Guide to Fluorescence Lifetime Microscopy and Förster's Resonance Energy Transfer in Neuroscience. CURRENT PROTOCOLS IN NEUROSCIENCE 2020; 94:e108. [PMID: 33232577 PMCID: PMC8274369 DOI: 10.1002/cpns.108] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Fluorescence lifetime microscopy (FLIM) and Förster's resonance energy transfer (FRET) are advanced optical tools that neuroscientists can employ to interrogate the structure and function of complex biological systems in vitro and in vivo using light. In neurobiology they are primarily used to study protein-protein interactions, to study conformational changes in protein complexes, and to monitor genetically encoded FRET-based biosensors. These methods are ideally suited to optically monitor changes in neurons that are triggered optogenetically. Utilization of this technique by neuroscientists has been limited, since a broad understanding of FLIM and FRET requires familiarity with the interactions of light and matter on a quantum mechanical level, and because the ultra-fast instrumentation used to measure fluorescent lifetimes and resonance energy transfer are more at home in a physics lab than in a biology lab. In this overview, we aim to help neuroscientists overcome these obstacles and thus feel more comfortable with the FLIM-FRET method. Our goal is to aid researchers in the neuroscience community to achieve a better understanding of the fundamentals of FLIM-FRET and encourage them to fully leverage its powerful ability as a research tool. Published 2020. U.S. Government.
Collapse
Affiliation(s)
- Daniel J. Liput
- Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, Maryland
- Laboratory of Molecular Physiology, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, Maryland
| | - Tuan A. Nguyen
- Laboratory of Biophotonics and Quantum Biology, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, Maryland
| | - Shana M. Augustin
- Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, Maryland
| | - Jeong Oen Lee
- Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, Maryland
| | - Steven S. Vogel
- Laboratory of Biophotonics and Quantum Biology, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, Maryland
- Corresponding author:
| |
Collapse
|
104
|
Woods GA, Rommelfanger NJ, Hong G. Bioinspired Materials for In Vivo Bioelectronic Neural Interfaces. MATTER 2020; 3:1087-1113. [PMID: 33103115 PMCID: PMC7583599 DOI: 10.1016/j.matt.2020.08.002] [Citation(s) in RCA: 28] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/04/2023]
Abstract
The success of in vivo neural interfaces relies on their long-term stability and large scale in interrogating and manipulating neural activity after implantation. Conventional neural probes, owing to their limited spatiotemporal resolution and scale, face challenges for studying the massive, interconnected neural network in its native state. In this review, we argue that taking inspiration from biology will unlock the next generation of in vivo bioelectronic neural interfaces. Reducing the feature sizes of bioelectronic neural interfaces to mimic those of neurons enables high spatial resolution and multiplexity. Additionally, chronic stability at the device-tissue interface is realized by matching the mechanical properties of bioelectronic neural interfaces to those of the endogenous tissue. Further, modeling the design of neural interfaces after the endogenous topology of the neural circuitry enables new insights into the connectivity and dynamics of the brain. Lastly, functionalization of neural probe surfaces with coatings inspired by biology leads to enhanced tissue acceptance over extended timescales. Bioinspired neural interfaces will facilitate future developments in neuroscience studies and neurological treatments by leveraging bidirectional information transfer and integrating neuromorphic computing elements.
Collapse
Affiliation(s)
- Grace A. Woods
- Department of Applied Physics, Stanford University, Stanford, California, 94305, USA
- Wu Tsai Neurosciences Institute, Stanford University, Stanford, California, 94305, USA
| | - Nicholas J. Rommelfanger
- Department of Applied Physics, Stanford University, Stanford, California, 94305, USA
- Wu Tsai Neurosciences Institute, Stanford University, Stanford, California, 94305, USA
| | - Guosong Hong
- Department of Materials Science and Engineering, Stanford University, Stanford, California, 94305, USA
- Wu Tsai Neurosciences Institute, Stanford University, Stanford, California, 94305, USA
| |
Collapse
|
105
|
Kessler A, Yoo M, Calisoff R. Complex regional pain syndrome: An updated comprehensive review. NeuroRehabilitation 2020; 47:253-264. [PMID: 32986618 DOI: 10.3233/nre-208001] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Complex regional pain syndrome (CRPS) is a complex disorder that can have a significant impact on the quality of life of a person with this syndrome. The diagnosis and treatment of CRPS are often difficult as there is no one confirmatory test and no one definitive treatment. Currently, the most widely accepted clinical diagnostic criteria are the Budapest criteria, which were developed by expert consensus. Though no one single treatment has been found to be universally effective, early detection and an interdisciplinary approach to treatment appear to be key in treating CRPS. This review aims to present up-to-date clinical information regarding the diagnosis and management of CRPS and highlight the potential issues with diagnosis in the neurological population. Ultimately, more research is needed to identify the exact etiology of CRPS in order to help target appropriate therapies. In addition, more randomized controlled trials need to be performed in order to test new therapies or combinations of therapies, including pharmacological, interventional, and behavioral therapies, to determine the best treatment options for this potentially debilitating disorder.
Collapse
Affiliation(s)
- Allison Kessler
- Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL, USA.,Shirley Ryan Abilitylab, Chicago, IL, USA
| | - Min Yoo
- Department of Physical Medicine and Rehabilitation, Mayo Clinic Arizona, Scottsdale, AZ, USA
| | - Randy Calisoff
- Department of Physical Medicine and Rehabilitation, Northwestern Feinberg School of Medicine, Chicago, IL, USA.,Shirley Ryan Abilitylab, Chicago, IL, USA
| |
Collapse
|
106
|
Han M, Srivastava SB, Yildiz E, Melikov R, Surme S, Dogru-Yuksel IB, Kavakli IH, Sahin A, Nizamoglu S. Organic Photovoltaic Pseudocapacitors for Neurostimulation. ACS APPLIED MATERIALS & INTERFACES 2020; 12:42997-43008. [PMID: 32852189 PMCID: PMC7582621 DOI: 10.1021/acsami.0c11581] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/26/2020] [Accepted: 08/27/2020] [Indexed: 05/31/2023]
Abstract
Neural interfaces are the fundamental tools to understand the brain and cure many nervous-system diseases. For proper interfacing, seamless integration, efficient and safe digital-to-biological signal transduction, and long operational lifetime are required. Here, we devised a wireless optoelectronic pseudocapacitor converting the optical energy to safe capacitive currents by dissociating the photogenerated excitons in the photovoltaic unit and effectively routing the holes to the supercapacitor electrode and the pseudocapacitive electrode-electrolyte interfacial layer of PEDOT:PSS for reversible faradic reactions. The biointerface showed high peak capacitive currents of ∼3 mA·cm-2 with total charge injection of ∼1 μC·cm-2 at responsivity of 30 mA·W-1, generating high photovoltages over 400 mV for the main eye photoreception colors of blue, green, and red. Moreover, modification of PEDOT:PSS controls the charging/discharging phases leading to rapid capacitive photoresponse of 50 μs and effective membrane depolarization at the single-cell level. The neural interface has a device lifetime of over 1.5 years in the aqueous environment and showed stability without significant performance decrease after sterilization steps. Our results demonstrate that adopting the pseudocapacitance phenomenon on organic photovoltaics paves an ultraefficient, safe, and robust way toward communicating with biological systems.
Collapse
Affiliation(s)
- Mertcan Han
- Department
of Electrical and Electronics Engineering, Koc University, Istanbul 34450, Turkey
| | | | - Erdost Yildiz
- Koc
University Research Center for Translational Medicine, Koc University, Istanbul 34450, Turkey
| | - Rustamzhon Melikov
- Department
of Electrical and Electronics Engineering, Koc University, Istanbul 34450, Turkey
| | - Saliha Surme
- Molecular
Biology and Genetics, College of Science, Koc University, Istanbul 34450, Turkey
| | - Itir Bakis Dogru-Yuksel
- Graduate
School of Biomedical Sciences and Engineering, Koc University, Istanbul 34450, Turkey
| | - Ibrahim Halil Kavakli
- Molecular
Biology and Genetics, College of Science, Koc University, Istanbul 34450, Turkey
- College
of Engineering, Chemical and Biological Engineering, Koc University, Istanbul 34450, Turkey
| | - Afsun Sahin
- Koc
University Research Center for Translational Medicine, Koc University, Istanbul 34450, Turkey
- Department
of Ophthalmology, Medical School Koc University, Istanbul 34450, Turkey
| | - Sedat Nizamoglu
- Department
of Electrical and Electronics Engineering, Koc University, Istanbul 34450, Turkey
- Graduate
School of Biomedical Sciences and Engineering, Koc University, Istanbul 34450, Turkey
| |
Collapse
|
107
|
Döbrössy MD, Ramanathan C, Ashouri Vajari D, Tong Y, Schlaepfer T, Coenen VA. Neuromodulation in Psychiatric disorders: Experimental and Clinical evidence for reward and motivation network Deep Brain Stimulation: Focus on the medial forebrain bundle. Eur J Neurosci 2020; 53:89-113. [PMID: 32931064 DOI: 10.1111/ejn.14975] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2019] [Revised: 07/24/2020] [Accepted: 08/27/2020] [Indexed: 12/28/2022]
Abstract
Deep brain stimulation (DBS) in psychiatric illnesses has been clinically tested over the past 20 years. The clinical application of DBS to the superolateral branch of the medial forebrain bundle in treatment-resistant depressed patients-one of several targets under investigation-has shown to be promising in a number of uncontrolled open label trials. However, there are remain numerous questions that need to be investigated to understand and optimize the clinical use of DBS in depression, including, for example, the relationship between the symptoms, the biological substrates/projections and the stimulation itself. In the context of precision and customized medicine, the current paper focuses on clinical and experimental research of medial forebrain bundle DBS in depression or in animal models of depression, demonstrating how clinical and scientific progress can work in tandem to test the therapeutic value and investigate the mechanisms of this experimental treatment. As one of the hypotheses is that depression engenders changes in the reward and motivational networks, the review looks at how stimulation of the medial forebrain bundle impacts the dopaminergic system.
Collapse
Affiliation(s)
- Máté D Döbrössy
- Laboratory of Stereotaxy and Interventional Neurosciences, Department of Stereotactic and Functional Neurosurgery, University Hospital Freiburg, Freiburg, Germany.,Center for Basics in Neuromodulation, Freiburg University, Freiburg, Germany
| | - Chockalingam Ramanathan
- Laboratory of Stereotaxy and Interventional Neurosciences, Department of Stereotactic and Functional Neurosurgery, University Hospital Freiburg, Freiburg, Germany
| | - Danesh Ashouri Vajari
- Laboratory for Biomedical Microtechnology, Department of Microsystems Engineering, University of Freiburg, Freiburg, Germany
| | - Yixin Tong
- Laboratory of Stereotaxy and Interventional Neurosciences, Department of Stereotactic and Functional Neurosurgery, University Hospital Freiburg, Freiburg, Germany
| | - Thomas Schlaepfer
- Faculty of Medicine, University of Freiburg, Freiburg, Germany.,Department of Interventional Biological Psychiatry, University Hospital Freiburg, Freiburg, Germany
| | - Volker A Coenen
- Laboratory of Stereotaxy and Interventional Neurosciences, Department of Stereotactic and Functional Neurosurgery, University Hospital Freiburg, Freiburg, Germany.,Center for Basics in Neuromodulation, Freiburg University, Freiburg, Germany.,Faculty of Medicine, University of Freiburg, Freiburg, Germany.,Department of Stereotactic and Functional Neurosurgery, University Hospital Freiburg, Freiburg, Germany
| |
Collapse
|
108
|
Song M, Kim J, Shin H, Kim Y, Jang H, Park Y, Kim SJ. Development of Magnetic Torque Stimulation (MTS) Utilizing Rotating Uniform Magnetic Field for Mechanical Activation of Cardiac Cells. NANOMATERIALS 2020; 10:nano10091684. [PMID: 32867131 PMCID: PMC7557977 DOI: 10.3390/nano10091684] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/31/2020] [Revised: 08/21/2020] [Accepted: 08/24/2020] [Indexed: 12/13/2022]
Abstract
Regulation of cell signaling through physical stimulation is an emerging topic in biomedicine. Background: While recent advances in biophysical technologies show capabilities for spatiotemporal stimulation, interfacing those tools with biological systems for intact signal transfer and noncontact stimulation remains challenging. Here, we describe the use of a magnetic torque stimulation (MTS) system combined with engineered magnetic particles to apply forces on the surface of individual cells. MTS utilizes an externally rotating magnetic field to induce a spin on magnetic particles and generate torsional force to stimulate mechanotransduction pathways in two types of human heart cells—cardiomyocytes and cardiac fibroblasts. Methods: The MTS system operates in a noncontact mode with two magnets separated (60 mm) from each other and generates a torque of up to 15 pN µm across the entire area of a 35-mm cell culture dish. The MTS system can mechanically stimulate both types of human heart cells, inducing maturation and hypertrophy. Results: Our findings show that application of the MTS system under hypoxic conditions induces not only nuclear localization of mechanoresponsive YAP proteins in human heart cells but also overexpression of hypertrophy markers, including β-myosin heavy chain (βMHC), cardiotrophin-1 (CT-1), microRNA-21 (miR-21), and transforming growth factor beta-1 (TGFβ-1). Conclusions: These results have important implications for the applicability of the MTS system to diverse in vitro studies that require remote and noninvasive mechanical regulation.
Collapse
Affiliation(s)
- Myeongjin Song
- Department of Biomedical Sciences, College of Medicine, Korea University, Seoul 02841, Korea; (M.S.); (J.K.); (Y.K.); (H.J.)
| | - Jongseong Kim
- Department of Biomedical Sciences, College of Medicine, Korea University, Seoul 02841, Korea; (M.S.); (J.K.); (Y.K.); (H.J.)
| | - Hyundo Shin
- Department of Mechanical Engineering, Yonsei University, Seoul 03722, Korea;
| | - Yekwang Kim
- Department of Biomedical Sciences, College of Medicine, Korea University, Seoul 02841, Korea; (M.S.); (J.K.); (Y.K.); (H.J.)
| | - Hwanseok Jang
- Department of Biomedical Sciences, College of Medicine, Korea University, Seoul 02841, Korea; (M.S.); (J.K.); (Y.K.); (H.J.)
| | - Yongdoo Park
- Department of Biomedical Sciences, College of Medicine, Korea University, Seoul 02841, Korea; (M.S.); (J.K.); (Y.K.); (H.J.)
- Correspondence: (Y.P.); (S.-J.K.); Tel.: +82-2-2286-1460 (Y.P.)
| | - Seung-Jong Kim
- Department of Biomedical Sciences, College of Medicine, Korea University, Seoul 02841, Korea; (M.S.); (J.K.); (Y.K.); (H.J.)
- Correspondence: (Y.P.); (S.-J.K.); Tel.: +82-2-2286-1460 (Y.P.)
| |
Collapse
|
109
|
Electric Field Application In Vivo Regulates Neural Precursor Cell Behavior in the Adult Mammalian Forebrain. eNeuro 2020; 7:ENEURO.0273-20.2020. [PMID: 32719101 PMCID: PMC7452733 DOI: 10.1523/eneuro.0273-20.2020] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2020] [Accepted: 06/23/2020] [Indexed: 01/02/2023] Open
Abstract
Deep brain stimulation (DBS), which uses electrical stimulation, is a well-established neurosurgical technique used to treat neurologic disorders. Despite its broad therapeutic use, the effects of electrical stimulation on brain cells is not fully understood. Here, we examine the effects of electrical stimulation on neural stem and progenitor cells (collectively neural precursor cells; NPCs) from the subventricular zone in the adult forebrain of C57BL/6J mice. Previous work has demonstrated that adult-derived NPCs are electro sensitive and undergo rapid and directed migration in response to application of clinically relevant electric fields (EFs). We examine NPC proliferation kinetics and their differentiation profile following EF application using in vitro and in vivo assays. In vitro direct current electrical stimulation of 250 mV/mm is sufficient to elicit a 2-fold increase in the neural stem cell pool and increases neurogenesis and oligogenesis. In vivo, asymmetric biphasic electrical stimulation similarly increases the size of the NPC pool and alters neurogenesis. These findings provide insight into the effects of electrical stimulation on NPCs and suggest its potential use as a regenerative approach to neural repair.
Collapse
|
110
|
Pyragas K, Fedaravičius AP, Pyragienė T, Tass PA. Entrainment of a network of interacting neurons with minimum stimulating charge. Phys Rev E 2020; 102:012221. [PMID: 32795011 DOI: 10.1103/physreve.102.012221] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2020] [Accepted: 07/07/2020] [Indexed: 11/07/2022]
Abstract
Periodic pulse train stimulation is generically used to study the function of the nervous system and to counteract disease-related neuronal activity, e.g., collective periodic neuronal oscillations. The efficient control of neuronal dynamics without compromising brain tissue is key to research and clinical purposes. We here adapt the minimum charge control theory, recently developed for a single neuron, to a network of interacting neurons exhibiting collective periodic oscillations. We present a general expression for the optimal waveform, which provides an entrainment of a neural network to the stimulation frequency with a minimum absolute value of the stimulating current. As in the case of a single neuron, the optimal waveform is of bang-off-bang type, but its parameters are now determined by the parameters of the effective phase response curve of the entire network, rather than of a single neuron. The theoretical results are confirmed by three specific examples: two small-scale networks of FitzHugh-Nagumo neurons with synaptic and electric couplings, as well as a large-scale network of synaptically coupled quadratic integrate-and-fire neurons.
Collapse
Affiliation(s)
- Kestutis Pyragas
- Center for Physical Sciences and Technology, LT-10257 Vilnius, Lithuania
| | | | - Tatjana Pyragienė
- Center for Physical Sciences and Technology, LT-10257 Vilnius, Lithuania
| | - Peter A Tass
- Department of Neurosurgery, Stanford University, Stanford, California 94305, USA
| |
Collapse
|
111
|
Lozano A, Suárez JS, Soto-Sánchez C, Garrigós J, Martínez-Alvarez JJ, Ferrández JM, Fernández E. Neurolight: A Deep Learning Neural Interface for Cortical Visual Prostheses. Int J Neural Syst 2020; 30:2050045. [DOI: 10.1142/s0129065720500458] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Visual neuroprosthesis, that provide electrical stimulation along several sites of the human visual system, constitute a potential tool for vision restoration for the blind. Scientific and technological progress in the fields of neural engineering and artificial vision comes with new theories and tools that, along with the dawn of modern artificial intelligence, constitute a promising framework for the further development of neurotechnology. In the framework of the development of a Cortical Visual Neuroprosthesis for the blind (CORTIVIS), we are now facing the challenge of developing not only computationally powerful tools and flexible approaches that will allow us to provide some degree of functional vision to individuals who are profoundly blind. In this work, we propose a general neuroprosthesis framework composed of several task-oriented and visual encoding modules. We address the development and implementation of computational models of the firing rates of retinal ganglion cells and design a tool — Neurolight — that allows these models to be interfaced with intracortical microelectrodes in order to create electrical stimulation patterns that can evoke useful perceptions. In addition, the developed framework allows the deployment of a diverse array of state-of-the-art deep-learning techniques for task-oriented and general image pre-processing, such as semantic segmentation and object detection in our system’s pipeline. To the best of our knowledge, this constitutes the first deep-learning-based system designed to directly interface with the visual brain through an intracortical microelectrode array. We implement the complete pipeline, from obtaining a video stream to developing and deploying task-oriented deep-learning models and predictive models of retinal ganglion cells’ encoding of visual inputs under the control of a neurostimulation device able to send electrical train pulses to a microelectrode array implanted at the visual cortex.
Collapse
Affiliation(s)
- Antonio Lozano
- Departamento de Electrónica, Tecnología de Computadoras y Proyectos, Universidad Politécnica de Cartagena, 30202 Cartagena, Spain
| | - Juan Sebastián Suárez
- Instituto de Bioingeniería, Universidad Miguel Hernández, 03202 Alicante, Spain
- CIBER-BBN, 28029 Madrid, Spain
| | - Cristina Soto-Sánchez
- Instituto de Bioingeniería, Universidad Miguel Hernández, 03202 Alicante, Spain
- CIBER-BBN, 28029 Madrid, Spain
| | - Javier Garrigós
- Departamento de Electrónica, Tecnología de Computadoras y Proyectos, Universidad Politécnica de Cartagena, 30202 Cartagena, Spain
| | - J. Javier Martínez-Alvarez
- Departamento de Electrónica, Tecnología de Computadoras y Proyectos, Universidad Politécnica de Cartagena, 30202 Cartagena, Spain
| | - J. Manuel Ferrández
- Departamento de Electrónica, Tecnología de Computadoras y Proyectos, Universidad Politécnica de Cartagena, 30202 Cartagena, Spain
| | - Eduardo Fernández
- Instituto de Bioingeniería, Universidad Miguel Hernández, 03202 Alicante, Spain
| |
Collapse
|
112
|
Effects of Subthalamic Nucleus Deep Brain Stimulation on Facial Emotion Recognition in Parkinson's Disease: A Critical Literature Review. Behav Neurol 2020; 2020:4329297. [PMID: 32724481 PMCID: PMC7382738 DOI: 10.1155/2020/4329297] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2020] [Accepted: 06/12/2020] [Indexed: 01/04/2023] Open
Abstract
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an effective therapy for Parkinson's disease (PD). Nevertheless, DBS has been associated with certain nonmotor, neuropsychiatric effects such as worsening of emotion recognition from facial expressions. In order to investigate facial emotion recognition (FER) after STN DBS, we conducted a literature search of the electronic databases MEDLINE and Web of science. In this review, we analyze studies assessing FER after STN DBS in PD patients and summarize the current knowledge of the effects of STN DBS on FER. The majority of studies, which had clinical and methodological heterogeneity, showed that FER is worsening after STN DBS in PD patients, particularly for negative emotions (sadness, fear, anger, and tendency for disgust). FER worsening after STN DBS can be attributed to the functional role of the STN in limbic circuits and the interference of STN stimulation with neural networks involved in FER, including the connections of the STN with the limbic part of the basal ganglia and pre- and frontal areas. These outcomes improve our understanding of the role of the STN in the integration of motor, cognitive, and emotional aspects of behaviour in the growing field of affective neuroscience. Further studies using standardized neuropsychological measures of FER assessment and including larger cohorts are needed, in order to draw definite conclusions about the effect of STN DBS on emotional recognition and its impact on patients' quality of life.
Collapse
|
113
|
Green AL, Paterson DJ. Using Deep Brain Stimulation to Unravel the Mysteries of Cardiorespiratory Control. Compr Physiol 2020; 10:1085-1104. [PMID: 32941690 DOI: 10.1002/cphy.c190039] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
This article charts the history of deep brain stimulation (DBS) as applied to alleviate a number of neurological disorders, while in parallel mapping the electrophysiological circuits involved in generating and integrating neural signals driving the cardiorespiratory system during exercise. With the advent of improved neuroimaging techniques, neurosurgeons can place small electrodes into deep brain structures with a high degree accuracy to treat a number of neurological disorders, such as movement impairment associated with Parkinson's disease and neuropathic pain. As well as stimulating discrete nuclei and monitoring autonomic outflow, local field potentials can also assess how the neurocircuitry responds to exercise. This technique has provided an opportunity to validate in humans putative circuits previously identified in animal models. The central autonomic network consists of multiple sites from the spinal cord to the cortex involved in autonomic control. Important areas exist at multiple evolutionary levels, which include the anterior cingulate cortex (telencephalon), hypothalamus (diencephalon), periaqueductal grey (midbrain), parabrachial nucleus and nucleus of the tractus solitaries (brainstem), and the intermediolateral column of the spinal cord. These areas receive afferent input from all over the body and provide a site for integration, resulting in a coordinated efferent autonomic (sympathetic and parasympathetic) response. In particular, emerging evidence from DBS studies have identified the basal ganglia as a major sub-cortical cognitive integrator of both higher center and peripheral afferent feedback. These circuits in the basal ganglia appear to be central in coupling movement to the cardiorespiratory motor program. © 2020 American Physiological Society. Compr Physiol 10:1085-1104, 2020.
Collapse
Affiliation(s)
- Alexander L Green
- Division of Medical Sciences, Department of Clinical Neurosciences, University of Oxford, Oxford, UK
| | - David J Paterson
- Department of Physiology Anatomy and Genetics, University of Oxford, Oxford, UK
| |
Collapse
|
114
|
Fakhrieh‐Asl G, Sadr SS, Karimian SM, Riahi E. Deep brain stimulation of the orbitofrontal cortex prevents the development and reinstatement of morphine place preference. Addict Biol 2020; 25:e12780. [PMID: 31210397 DOI: 10.1111/adb.12780] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2018] [Revised: 02/27/2019] [Accepted: 05/02/2019] [Indexed: 02/04/2023]
Abstract
The orbitofrontal cortex (OFC) is involved in compulsive drug seeking and drug relapse. Its involvement in cue-, context-, and stress-induced reinstatement of drug seeking has also been confirmed in animal models. Deep brain stimulation (DBS) was proposed to be an effective intervention for patients with treatment-refractory addiction. Therefore, in the present study, we investigated the potential efficacy of DBS in the OFC for controlling addictive-like behaviors in rats. Rats were bilaterally implanted with electrodes in the OFC and trained to the morphine conditioned place preference (CPP; 3, 5, and 7 mg/kg). High-frequency (HF; 130 Hz) or low-frequency (LF; 13 Hz) DBS-like stimulation was applied during the conditioning (40 minutes, once daily, 3 days) or extinction (20 minutes, once daily, 6-10 days) trials. Following the extinction, morphine preference was reinstated by a priming dose of morphine (2 mg/kg). When applied during the conditioning phase, HF-DBS significantly decreased preference for the morphine-associated context. HF-DBS during the extinction phase of morphine CPP reduced the number of days to full extinction of morphine preference and prevented morphine priming-induced recurrence of morphine preference. LF-DBS did not change any of these addictive behaviors. HF-DBS had no significant effect on novel object recognition memory. In conclusion, HF-DBS of the OFC prevented morphine preference, facilitated extinction of morphine preference, and blocked drug priming-induced reinstatement of morphine seeking. These findings may indicate a potential applicability of DBS in the treatment of relapse to drug use. Further studies will be necessary to assess the translatability of these findings to the clinic.
Collapse
Affiliation(s)
- Golnaz Fakhrieh‐Asl
- Electrophysiology Research Center, Neuroscience Institute Tehran University of Medical Sciences Tehran Iran
- Department of Physiology, School of Medicine Tehran University of Medical Sciences Tehran Iran
| | - Seyed Shahabeddin Sadr
- Electrophysiology Research Center, Neuroscience Institute Tehran University of Medical Sciences Tehran Iran
- Department of Physiology, School of Medicine Tehran University of Medical Sciences Tehran Iran
| | - Seyed Morteza Karimian
- Department of Physiology, School of Medicine Tehran University of Medical Sciences Tehran Iran
| | - Esmail Riahi
- Department of Physiology, School of Medicine Tehran University of Medical Sciences Tehran Iran
| |
Collapse
|
115
|
Jafari Z, Kolb BE, Mohajerani MH. Neural oscillations and brain stimulation in Alzheimer's disease. Prog Neurobiol 2020; 194:101878. [PMID: 32615147 DOI: 10.1016/j.pneurobio.2020.101878] [Citation(s) in RCA: 80] [Impact Index Per Article: 20.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2019] [Revised: 12/20/2019] [Accepted: 06/25/2020] [Indexed: 12/30/2022]
Abstract
Aging is associated with alterations in cognitive processing and brain neurophysiology. Whereas the primary symptom of amnestic mild cognitive impairment (aMCI) is memory problems greater than normal for age and education, patients with Alzheimer's disease (AD) show impairments in other cognitive domains in addition to memory dysfunction. Resting-state electroencephalography (rsEEG) studies in physiological aging indicate a global increase in low-frequency oscillations' power and the reduction and slowing of alpha activity. The enhancement of slow and the reduction of fast oscillations, and the disruption of brain functional connectivity, however, are characterized as major rsEEG changes in AD. Recent rodent studies also support human evidence of age- and AD-related changes in resting-state brain oscillations, and the neuroprotective effect of brain stimulation techniques through gamma-band stimulations. Cumulatively, current evidence moves toward optimizing rsEEG features as reliable predictors of people with aMCI at risk for conversion to AD and mapping neural alterations subsequent to brain stimulation therapies. The present paper reviews the latest evidence of changes in rsEEG oscillations in physiological aging, aMCI, and AD, as well as findings of various brain stimulation therapies from both human and non-human studies.
Collapse
Affiliation(s)
- Zahra Jafari
- Department of Neuroscience, Canadian Centre for Behavioural Neuroscience, University of Lethbridge, Lethbridge, AB, T1K 3M4, Canada
| | - Bryan E Kolb
- Department of Neuroscience, Canadian Centre for Behavioural Neuroscience, University of Lethbridge, Lethbridge, AB, T1K 3M4, Canada.
| | - Majid H Mohajerani
- Department of Neuroscience, Canadian Centre for Behavioural Neuroscience, University of Lethbridge, Lethbridge, AB, T1K 3M4, Canada.
| |
Collapse
|
116
|
Bogdan ID, van Laar T, Oterdoom DM, Drost G, van Dijk JMC, Beudel M. Optimal Parameters of Deep Brain Stimulation in Essential Tremor: A Meta-Analysis and Novel Programming Strategy. J Clin Med 2020; 9:jcm9061855. [PMID: 32545887 PMCID: PMC7356338 DOI: 10.3390/jcm9061855] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2020] [Revised: 06/04/2020] [Accepted: 06/09/2020] [Indexed: 01/10/2023] Open
Abstract
The programming of deep brain stimulation (DBS) parameters for tremor is laborious and empirical. Despite extensive efforts, the end-result is often suboptimal. One reason for this is the poorly understood relationship between the stimulation parameters’ voltage, pulse width, and frequency. In this study, we aim to improve DBS programming for essential tremor (ET) by exploring a new strategy. At first, the role of the individual DBS parameters in tremor control was characterized using a meta-analysis documenting all the available parameters and tremor outcomes. In our novel programming strategy, we applied 10 random combinations of stimulation parameters in eight ET-DBS patients with suboptimal tremor control. Tremor severity was assessed using accelerometers and immediate and sustained patient-reported outcomes (PRO’s), including the occurrence of side-effects. The meta-analysis showed no substantial relationship between individual DBS parameters and tremor suppression. Nevertheless, with our novel programming strategy, a significantly improved (accelerometer p = 0.02, PRO p = 0.02) and sustained (p = 0.01) tremor suppression compared to baseline was achieved. Less side-effects were encountered compared to baseline. Our pilot data show that with this novel approach, tremor control can be improved in ET patients with suboptimal tremor control on DBS. In addition, this approach proved to have a beneficial effect on stimulation-related complications.
Collapse
Affiliation(s)
- I. Daria Bogdan
- Department of Neurology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands; (I.D.B.); (G.D.)
- Department of Neurosurgery, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands; (D.L.M.O.); (J.M.C.v.D.)
| | - Teus van Laar
- Department of Neurology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands; (I.D.B.); (G.D.)
- Correspondence:
| | - D.L. Marinus Oterdoom
- Department of Neurosurgery, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands; (D.L.M.O.); (J.M.C.v.D.)
| | - Gea Drost
- Department of Neurology, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands; (I.D.B.); (G.D.)
- Department of Neurosurgery, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands; (D.L.M.O.); (J.M.C.v.D.)
| | - J. Marc C. van Dijk
- Department of Neurosurgery, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, The Netherlands; (D.L.M.O.); (J.M.C.v.D.)
| | - Martijn Beudel
- Department of Neurology, Amsterdam Neuroscience Institute, Amsterdam University Medical Center, 1007 MB Amsterdam, The Netherlands;
| |
Collapse
|
117
|
Multivariate pattern classification on BOLD activation pattern induced by deep brain stimulation in motor, associative, and limbic brain networks. Sci Rep 2020; 10:7528. [PMID: 32372021 PMCID: PMC7200672 DOI: 10.1038/s41598-020-64547-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2019] [Accepted: 04/16/2020] [Indexed: 12/20/2022] Open
Abstract
Deep brain stimulation (DBS) has been shown to be an effective treatment for movement disorders and it is now being extended to the treatment of psychiatric disorders. Functional magnetic resonance imaging (fMRI) studies indicate that DBS stimulation targets dependent brain network effects, in networks that respond to stimulation. Characterizing these patterns is crucial for linking DBS-induced therapeutic and adverse effects. Conventional DBS-fMRI, however, lacks the sensitivity needed for decoding multidimensional information such as spatially diffuse patterns. We report here on the use of a multivariate pattern analysis (MVPA) to demonstrate that stimulation of three DBS targets (STN, subthalamic nucleus; GPi, globus pallidus internus; NAc, nucleus accumbens) evoked a sufficiently distinctive blood-oxygen-level-dependent (BOLD) activation in swine brain. The findings indicate that STN and GPi evoke a similar motor network pattern, while NAc shows a districted associative and limbic pattern. The findings show that MVPA could be effectively applied to overlapping or sparse BOLD patterns which are often found in DBS. Future applications are expected employ MVPA fMRI to identify the proper stimulation target dependent brain circuitry for a DBS outcome.
Collapse
|
118
|
Adair D, Truong D, Esmaeilpour Z, Gebodh N, Borges H, Ho L, Bremner JD, Badran BW, Napadow V, Clark VP, Bikson M. Electrical stimulation of cranial nerves in cognition and disease. Brain Stimul 2020; 13:717-750. [PMID: 32289703 PMCID: PMC7196013 DOI: 10.1016/j.brs.2020.02.019] [Citation(s) in RCA: 72] [Impact Index Per Article: 18.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2019] [Revised: 02/13/2020] [Accepted: 02/17/2020] [Indexed: 02/06/2023] Open
Abstract
The cranial nerves are the pathways through which environmental information (sensation) is directly communicated to the brain, leading to perception, and giving rise to higher cognition. Because cranial nerves determine and modulate brain function, invasive and non-invasive cranial nerve electrical stimulation methods have applications in the clinical, behavioral, and cognitive domains. Among other neuromodulation approaches such as peripheral, transcranial and deep brain stimulation, cranial nerve stimulation is unique in allowing axon pathway-specific engagement of brain circuits, including thalamo-cortical networks. In this review we amalgamate relevant knowledge of 1) cranial nerve anatomy and biophysics; 2) evidence of the modulatory effects of cranial nerves on cognition; 3) clinical and behavioral outcomes of cranial nerve stimulation; and 4) biomarkers of nerve target engagement including physiology, electroencephalography, neuroimaging, and behavioral metrics. Existing non-invasive stimulation methods cannot feasibly activate the axons of only individual cranial nerves. Even with invasive stimulation methods, selective targeting of one nerve fiber type requires nuance since each nerve is composed of functionally distinct axon-types that differentially branch and can anastomose onto other nerves. None-the-less, precisely controlling stimulation parameters can aid in affecting distinct sets of axons, thus supporting specific actions on cognition and behavior. To this end, a rubric for reproducible dose-response stimulation parameters is defined here. Given that afferent cranial nerve axons project directly to the brain, targeting structures (e.g. thalamus, cortex) that are critical nodes in higher order brain networks, potent effects on cognition are plausible. We propose an intervention design framework based on driving cranial nerve pathways in targeted brain circuits, which are in turn linked to specific higher cognitive processes. State-of-the-art current flow models that are used to explain and design cranial-nerve-activating stimulation technology require multi-scale detail that includes: gross anatomy; skull foramina and superficial tissue layers; and precise nerve morphology. Detailed simulations also predict that some non-invasive electrical or magnetic stimulation approaches that do not intend to modulate cranial nerves per se, such as transcranial direct current stimulation (tDCS) and transcranial magnetic stimulation (TMS), may also modulate activity of specific cranial nerves. Much prior cranial nerve stimulation work was conceptually limited to the production of sensory perception, with individual titration of intensity based on the level of perception and tolerability. However, disregarding sensory emulation allows consideration of temporal stimulation patterns (axon recruitment) that modulate the tone of cortical networks independent of sensory cortices, without necessarily titrating perception. For example, leveraging the role of the thalamus as a gatekeeper for information to the cerebral cortex, preventing or enhancing the passage of specific information depending on the behavioral state. We show that properly parameterized computational models at multiple scales are needed to rationally optimize neuromodulation that target sets of cranial nerves, determining which and how specific brain circuitries are modulated, which can in turn influence cognition in a designed manner.
Collapse
Affiliation(s)
- Devin Adair
- Department of Biomedical Engineering, City College of New York, New York, NY, USA
| | - Dennis Truong
- Department of Biomedical Engineering, City College of New York, New York, NY, USA
| | - Zeinab Esmaeilpour
- Department of Biomedical Engineering, City College of New York, New York, NY, USA.
| | - Nigel Gebodh
- Department of Biomedical Engineering, City College of New York, New York, NY, USA
| | - Helen Borges
- Department of Biomedical Engineering, City College of New York, New York, NY, USA
| | - Libby Ho
- Department of Biomedical Engineering, City College of New York, New York, NY, USA
| | - J Douglas Bremner
- Department of Psychiatry & Behavioral Sciences and Radiology, Emory University School of Medicine, Atlanta, GA, USA; Atlanta VA Medical Center, Decatur, GA, USA
| | - Bashar W Badran
- Department of Psychiatry & Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA
| | - Vitaly Napadow
- Martinos Center for Biomedical Imaging, Department of Radiology, MGH, Harvard medical school, Boston, MA, USA
| | - Vincent P Clark
- Psychology Clinical Neuroscience Center, Dept. Psychology, MSC03-2220, University of New Mexico, Albuquerque, NM, 87131, USA; Department of Psychology, University of New Mexico, Albuquerque, NM, 87131, USA; The Mind Research Network of the Lovelace Biomedical Research Institute, 1101 Yale Blvd. NE, Albuquerque, NM, 87106, USA
| | - Marom Bikson
- Department of Biomedical Engineering, City College of New York, New York, NY, USA.
| |
Collapse
|
119
|
Hales S, Tokita E, Neupane R, Ghosh U, Elder B, Wirthlin D, Kong YL. 3D printed nanomaterial-based electronic, biomedical, and bioelectronic devices. NANOTECHNOLOGY 2020; 31:172001. [PMID: 31805540 DOI: 10.1088/1361-6528/ab5f29] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
The ability to seamlessly integrate functional materials into three-dimensional (3D) constructs has been of significant interest, as it can enable the creation of multifunctional devices. Such integration can be achieved with a multiscale, multi-material 3D printing strategy. This technology has enabled the creation of unique devices such as personalized tissue regenerative scaffolds, biomedical implants, 3D electronic devices, and bionic constructs which are challenging to realize with conventional manufacturing processes. In particular, the incorporation of nanomaterials into 3D printed devices can endow a wide range of constructs with tailorable mechanical, chemical, and electrical functionalities. This review highlights the advances and unique possibilities in the fabrication of novel electronic, biomedical, and bioelectronic devices that are realized by the synergistic integration of nanomaterials with 3D printing technologies.
Collapse
Affiliation(s)
- Samuel Hales
- Department of Mechanical Engineering, University of Utah, Salt Lake City, UT 84112, United States of America
| | | | | | | | | | | | | |
Collapse
|
120
|
Baker M, Hong SI, Kang S, Choi DS. Rodent models for psychiatric disorders: problems and promises. Lab Anim Res 2020; 36:9. [PMID: 32322555 PMCID: PMC7161141 DOI: 10.1186/s42826-020-00039-z] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2020] [Accepted: 03/03/2020] [Indexed: 01/19/2023] Open
Abstract
Psychiatric disorders are a prevalent global health problem, over 900 million individuals affected by a continuum of mental and substance use disorders. Due to this high prevalence, and the substantial direct and indirect societal costs, it is essential to understand the underlying mechanisms of these disorders to facilitate development of new and more effective treatments. Since the advent of recombinant DNA technologies in the early 1980s, genetically modified rodent models have significantly contributed to the genetic and molecular basis of psychiatric disorders. Despite significant advancements, many challenges remain after unsuccessful drug development based on rodent models. Recent human genetics show the polygenetic nature of mental disorders, identifying hundreds of allelic variants that confer increased risk. However, given the complexity of the brain, with many unique cell types, gene expression profiles, and developmental trajectories, proper animal models are needed more than ever to dissect genes and circuits in a cell type-specific manner to advance our understanding and treatment of psychiatric disorders. In this mini-review, we highlight current challenges and promises of using rodent models in advancing science and drug development, focusing on advanced techniques, and their applications to rodent models of psychiatric disorders.
Collapse
Affiliation(s)
- Matthew Baker
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905 USA
| | - Sa-Ik Hong
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905 USA
| | - Seungwoo Kang
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905 USA
| | - Doo-Sup Choi
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905 USA
- Neuroscience Program, Rochester, MN USA
- Department of Psychiatry and Psychology, Mayo Clinic College of Medicine, Rochester, MN USA
| |
Collapse
|
121
|
Abstract
OBJECTIVE Deep brain stimulation (DBS) was approved by Food and Drug Administration for Parkinson's disease, essential tremor, primary generalised or segmental dystonia and obsessive-compulsive disorder (OCD) treatment. The exact mechanism of DBS remains unclear which causes side effects. The aim of this review was to assess variables causing stimulation-induced chronic psychiatric/personality-changing side effects. METHODS The analysis of scientific database (PubMed, Cochrane Library, EMBASE) was conducted. The included articles had to be research study or case report and DBS to be conducted in therapeutic purposes. The researches with mental disorders in patients' medical histories were excluded. RESULTS Seventeen articles were used in the review. In the group of movement disorders the characteristic of side effects was strongly related to the placement of the electrode implantation. Tiredness/fatigue was correlated with DBS in thalamus. Implantations in subthalamic nucleus were mostly followed by affective side effects such as depression or suicide. The higher voltage of electrode was connected with more severe depression after implantation. The analysis of affective disorder contained only three articles - two about OCD and one about depression. Forgetfulness and word-finding problems as activities connected with cognition may be an inevitable side effect if obsessive thoughts are to be inhibited. CONCLUSION DBS of subthalamic nucleus should be seen as the most hazardous place of implantation. As a result there is a strong need of 'gold standards' based on the connectivity research and closer cooperation of scientists and clinicians.
Collapse
|
122
|
Das R, Moradi F, Heidari H. Biointegrated and Wirelessly Powered Implantable Brain Devices: A Review. IEEE TRANSACTIONS ON BIOMEDICAL CIRCUITS AND SYSTEMS 2020; 14:343-358. [PMID: 31944987 DOI: 10.1109/tbcas.2020.2966920] [Citation(s) in RCA: 40] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/07/2023]
|
123
|
Won SM, Song E, Reeder JT, Rogers JA. Emerging Modalities and Implantable Technologies for Neuromodulation. Cell 2020; 181:115-135. [DOI: 10.1016/j.cell.2020.02.054] [Citation(s) in RCA: 63] [Impact Index Per Article: 15.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2020] [Revised: 02/23/2020] [Accepted: 02/25/2020] [Indexed: 02/08/2023]
|
124
|
Tomaskovic-Crook E, Gu Q, Rahim SNA, Wallace GG, Crook JM. Conducting Polymer Mediated Electrical Stimulation Induces Multilineage Differentiation with Robust Neuronal Fate Determination of Human Induced Pluripotent Stem Cells. Cells 2020; 9:cells9030658. [PMID: 32182797 PMCID: PMC7140718 DOI: 10.3390/cells9030658] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2020] [Revised: 02/28/2020] [Accepted: 03/04/2020] [Indexed: 12/15/2022] Open
Abstract
Electrical stimulation is increasingly being used to modulate human cell behaviour for biotechnological research and therapeutics. Electrically conductive polymers (CPs) such as polypyrrole (PPy) are amenable to in vitro and in vivo cell stimulation, being easy to synthesise with different counter ions (dopants) to augment biocompatibility and cell-effects. Extending our earlier work, which showed that CP-mediated electrical stimulation promotes human neural stem cell differentiation, here we report using electroactive PPy containing the anionic dopant dodecylbenzenesulfonate (DBS) to modulate the fate determination of human induced pluripotent stem cells (iPSCs). Remarkably, the stimulation without conventional chemical inducers resulted in the iPSCs differentiating to cells of the three germ lineages-endoderm, ectoderm, and mesoderm. The unstimulated iPSC controls remained undifferentiated. Phenotypic characterisation further showed a robust induction to neuronal fate with electrical stimulation, again without customary chemical inducers. Our findings add to the growing body of evidence supporting the use of electrical stimulation to augment stem cell differentiation, more specifically, pluripotent stem cell differentiation, and especially neuronal induction. Moreover, we have shown the versatility of electroactive PPy as a cell-compatible platform for advanced stem cell research and translation, including identifying novel mechanisms of fate regulation, tissue development, electroceuticals, and regenerative medicine.
Collapse
Affiliation(s)
- Eva Tomaskovic-Crook
- ARC Centre of Excellence for Electromaterials Science, Intelligent Polymer Research Institute, AIIM Facility, University of Wollongong, 2500 Wollongong, Australia; (E.T.-C.); (Q.G.); (S.N.A.R.)
- Illawarra Health and Medical Research Institute, University of Wollongong, 2500 Wollongong, Australia
| | - Qi Gu
- ARC Centre of Excellence for Electromaterials Science, Intelligent Polymer Research Institute, AIIM Facility, University of Wollongong, 2500 Wollongong, Australia; (E.T.-C.); (Q.G.); (S.N.A.R.)
- State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, 100000 Beijing, China
| | - Siti N Abdul Rahim
- ARC Centre of Excellence for Electromaterials Science, Intelligent Polymer Research Institute, AIIM Facility, University of Wollongong, 2500 Wollongong, Australia; (E.T.-C.); (Q.G.); (S.N.A.R.)
| | - Gordon G Wallace
- ARC Centre of Excellence for Electromaterials Science, Intelligent Polymer Research Institute, AIIM Facility, University of Wollongong, 2500 Wollongong, Australia; (E.T.-C.); (Q.G.); (S.N.A.R.)
- Correspondence: (G.G.W.); (J.M.C.); Tel.: +61-2-4221-3127 (G.G.W.); +61-2-4221-3011 (J.M.C.)
| | - Jeremy M Crook
- ARC Centre of Excellence for Electromaterials Science, Intelligent Polymer Research Institute, AIIM Facility, University of Wollongong, 2500 Wollongong, Australia; (E.T.-C.); (Q.G.); (S.N.A.R.)
- Illawarra Health and Medical Research Institute, University of Wollongong, 2500 Wollongong, Australia
- Department of Surgery, St Vincent’s Hospital, The University of Melbourne, 3065 Fitzroy, Australia
- Correspondence: (G.G.W.); (J.M.C.); Tel.: +61-2-4221-3127 (G.G.W.); +61-2-4221-3011 (J.M.C.)
| |
Collapse
|
125
|
Schumm SN, Gabrieli D, Meaney DF. Neuronal Degeneration Impairs Rhythms Between Connected Microcircuits. Front Comput Neurosci 2020; 14:18. [PMID: 32194390 PMCID: PMC7063469 DOI: 10.3389/fncom.2020.00018] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2019] [Accepted: 02/11/2020] [Indexed: 11/23/2022] Open
Abstract
Synchronization of neural activity across brain regions is critical to processes that include perception, learning, and memory. After traumatic brain injury (TBI), neuronal degeneration is one possible effect and can alter communication between neural circuits. Consequently, synchronization between neurons may change and can contribute to both lasting changes in functional brain networks and cognitive impairment in patients. However, fundamental principles relating exactly how TBI at the cellular scale affects synchronization of mesoscale circuits are not well understood. In this work, we use computational networks of Izhikevich integrate-and-fire neurons to study synchronized, oscillatory activity between clusters of neurons, which also adapt according to spike-timing-dependent plasticity (STDP). We study how the connections within and between these neuronal clusters change as unidirectional connections form between the two neuronal populations. In turn, we examine how neuronal deletion, intended to mimic the temporary or permanent loss of neurons in the mesoscale circuit, affects these dynamics. We determine synchronization of two neuronal circuits requires very modest connectivity between these populations; approximately 10% of neurons projecting from one circuit to another circuit will result in high synchronization. In addition, we find that synchronization level inversely affects the strength of connection between neuronal microcircuits - moderately synchronized microcircuits develop stronger intercluster connections than do highly synchronized circuits. Finally, we find that highly synchronized circuits are largely protected against the effects of neuronal deletion but may display changes in frequency properties across circuits with targeted neuronal loss. Together, our results suggest that strongly and weakly connected regions differ in their inherent resilience to damage and may serve different roles in a larger network.
Collapse
Affiliation(s)
- Samantha N. Schumm
- Department of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA, United States
| | - David Gabrieli
- Department of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA, United States
| | - David F. Meaney
- Department of Bioengineering, School of Engineering and Applied Sciences, University of Pennsylvania, Philadelphia, PA, United States
- Penn Center for Brain Injury and Repair, Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States
| |
Collapse
|
126
|
Manjakkal L, Dervin S, Dahiya R. Flexible potentiometric pH sensors for wearable systems. RSC Adv 2020; 10:8594-8617. [PMID: 35496561 PMCID: PMC9050124 DOI: 10.1039/d0ra00016g] [Citation(s) in RCA: 64] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2020] [Revised: 03/30/2020] [Accepted: 02/15/2020] [Indexed: 12/21/2022] Open
Abstract
There is a growing demand for developing wearable sensors that can non-invasively detect the signs of chronic diseases early on to possibly enable self-health management. Among these the flexible and stretchable electrochemical pH sensors are particularly important as the pH levels influence most chemical and biological reactions in materials, life and environmental sciences. In this review, we discuss the most recent developments in wearable electrochemical potentiometric pH sensors, covering the key topics such as (i) suitability of potentiometric pH sensors in wearable systems; (ii) designs of flexible potentiometric pH sensors, which may vary with target applications; (iii) materials for various components of the sensor such as substrates, reference and sensitive electrode; (iv) applications of flexible potentiometric pH sensors, and (v) the challenges relating to flexible potentiometric pH sensors.
Collapse
Affiliation(s)
- Libu Manjakkal
- Bendable Electronics and Sensing Technologies (BEST) Group, School of Engineering, University of Glasgow G12 8QQ UK
| | - Saoirse Dervin
- Bendable Electronics and Sensing Technologies (BEST) Group, School of Engineering, University of Glasgow G12 8QQ UK
| | - Ravinder Dahiya
- Bendable Electronics and Sensing Technologies (BEST) Group, School of Engineering, University of Glasgow G12 8QQ UK
| |
Collapse
|
127
|
Morand-Beaulieu S, Leclerc JB. [Tourette syndrome: Research challenges to improve clinical practice]. Encephale 2020; 46:146-152. [PMID: 32014239 DOI: 10.1016/j.encep.2019.10.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2019] [Revised: 10/07/2019] [Accepted: 10/20/2019] [Indexed: 12/01/2022]
Abstract
Tourette syndrome is a neurodevelopmental disorder which is characterized by the presence of motor and phonic tics. These tics are generally more prevalent in childhood. Tics typically reach their maximum severity before puberty, around age 10 to 12. In most patients, tic severity usually decreases during late adolescence and adulthood. However, this is not true for all individuals. To date, the developmental trajectory leading to the persistence of tics into adulthood is still poorly understood. There are very few markers that can predict the evolution of tic symptoms from childhood to adulthood. Yet, while we cannot cure Tourette syndrome, it is possible to reduce tic severity with various treatments. The most common treatments are pharmacotherapy and behavioral and cognitive-behavioral therapy. However, there appears to be a limit to the proportion of tics that can be treated, since most treatments offer an average reduction in tics of no more than 50%. Thus, at first, this article reviews recent advances in treatment and symptom progression. Next, we propose some lines of research to improve the management and treatment of people with Tourette syndrome.
Collapse
Affiliation(s)
- S Morand-Beaulieu
- Child Study Center, Yale School of Medicine, New Haven, CT, USA; Centre de recherche de l'Institut universitaire en santé mentale de Montréal, Montréal, QC, Canada; Département de neurosciences, Université de Montréal, Montréal, QC, Canada.
| | - J B Leclerc
- Centre de recherche de l'Institut universitaire en santé mentale de Montréal, Montréal, QC, Canada; Département de psychologie, Université du Québec à Montréal, Montréal, QC, Canada
| |
Collapse
|
128
|
Khizroev S, Liang P. Engineering Future Medicines With Magnetoelectric Nanoparticles: Wirelessly controlled, targeted therapies. IEEE NANOTECHNOLOGY MAGAZINE 2020. [DOI: 10.1109/mnano.2019.2952227] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
129
|
Constans C, Ahnine H, Santin M, Lehericy S, Tanter M, Pouget P, Aubry JF. Non-invasive ultrasonic modulation of visual evoked response by GABA delivery through the blood brain barrier. J Control Release 2020; 318:223-231. [DOI: 10.1016/j.jconrel.2019.12.006] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2019] [Revised: 10/25/2019] [Accepted: 12/05/2019] [Indexed: 11/25/2022]
|
130
|
Tan SZK, Fung ML, Koh J, Chan YS, Lim LW. The Paradoxical Effect of Deep Brain Stimulation on Memory. Aging Dis 2020; 11:179-190. [PMID: 32010491 PMCID: PMC6961776 DOI: 10.14336/ad.2019.0511] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2019] [Accepted: 05/11/2019] [Indexed: 12/21/2022] Open
Abstract
Deep brain stimulation (DBS) is a promising treatment for many memory-related disorders including dementia, anxiety, and addiction. However, the use of DBS can be a paradoxical conundrum-dementia treatments aim to improve memory, whereas anxiety or addiction treatments aim to suppress maladaptive memory. In this review, the key hypotheses on how DBS affects memory are highlighted. We consolidate the findings and conclusions from the current research on the effects of DBS on memory in attempt to make sense of the bidirectional nature of DBS in disrupting and enhancing memory. Based on the current literature, we hypothesize that the timing of DBS plays a key role in its contradictory effects, and therefore, we propose a consolidated model of how DBS can both disrupt and enhance memory.
Collapse
Affiliation(s)
- Shawn Zheng Kai Tan
- School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
| | - Man-Lung Fung
- School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
| | - Junhao Koh
- School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
| | - Ying-Shing Chan
- School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
| | - Lee Wei Lim
- School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
| |
Collapse
|
131
|
Takeuchi Y, Berényi A. Oscillotherapeutics - Time-targeted interventions in epilepsy and beyond. Neurosci Res 2020; 152:87-107. [PMID: 31954733 DOI: 10.1016/j.neures.2020.01.002] [Citation(s) in RCA: 30] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2019] [Revised: 12/18/2019] [Accepted: 12/19/2019] [Indexed: 02/09/2023]
Abstract
Oscillatory brain activities support many physiological functions from motor control to cognition. Disruptions of the normal oscillatory brain activities are commonly observed in neurological and psychiatric disorders including epilepsy, Parkinson's disease, Alzheimer's disease, schizophrenia, anxiety/trauma-related disorders, major depressive disorders, and drug addiction. Therefore, these disorders can be considered as common oscillation defects despite having distinct behavioral manifestations and genetic causes. Recent technical advances of neuronal activity recording and analysis have allowed us to study the pathological oscillations of each disorder as a possible biomarker of symptoms. Furthermore, recent advances in brain stimulation technologies enable time- and space-targeted interventions of the pathological oscillations of both neurological disorders and psychiatric disorders as possible targets for regulating their symptoms.
Collapse
Affiliation(s)
- Yuichi Takeuchi
- MTA-SZTE 'Momentum' Oscillatory Neuronal Networks Research Group, Department of Physiology, University of Szeged, Szeged, 6720, Hungary; Department of Neuropharmacology, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya, 467-8603, Japan.
| | - Antal Berényi
- MTA-SZTE 'Momentum' Oscillatory Neuronal Networks Research Group, Department of Physiology, University of Szeged, Szeged, 6720, Hungary; HCEMM-SZTE Magnetotherapeutics Research Group, University of Szeged, Szeged, 6720, Hungary; Neuroscience Institute, New York University, New York, NY 10016, USA.
| |
Collapse
|
132
|
Schumacher A, Haegele M, Spyth J, Moser A. Electrical high frequency stimulation of the nucleus accumbens shell does not modulate depressive-like behavior in rats. Behav Brain Res 2020; 378:112277. [DOI: 10.1016/j.bbr.2019.112277] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2019] [Revised: 09/17/2019] [Accepted: 10/02/2019] [Indexed: 12/20/2022]
|
133
|
Karimi F, Attarpour A, Amirfattahi R, Nezhad AZ. Computational analysis of non-invasive deep brain stimulation based on interfering electric fields. Phys Med Biol 2019; 64:235010. [PMID: 31661678 DOI: 10.1088/1361-6560/ab5229] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
Abstract
Neuromodulation modalities are used as effective treatments for some brain disorders. Non-invasive deep brain stimulation (NDBS) via temporally interfering electric fields has emerged recently as a non-invasive strategy for electrically stimulating deep regions in the brain. The objective of this study is to provide insight into the fundamental mechanisms of this strategy and assess the potential uses of this method through computational analysis. Analytical and numerical methods are used to compute the electric potential and field distributions generated during NDBS in homogeneous and inhomogeneous models of the brain. The computational results are used for specifying the activated area in the brain (macroscopic approach), and quantifying its relationships to the stimulation parameters. Two automatic algorithms, using artificial neural network (ANN), are developed for the homogeneous model with two and four electrode pairs to estimate stimulation parameters. Additionally, the extracellular potentials are coupled to the compartmental axon cable model to determine the responses of the neurons to the modulated electric field in two developed models and to evaluate the precise activated area location (microscopic approach). Our results show that although the shape of the activated area was different in macroscopic and microscopic approaches, it located only at depth. Our optimization algorithms showed significant accuracy in estimating stimulation parameters. Moreover, it demonstrated that the more the electrode pairs, the more controllable the activated area. Finally, compartmental axon cable modeling results verified that neurons can demodulate and follow the electric field modulation envelope amplitude (MEA) in our models. The results of this study help develop the NDBS method and eliminate some limitations associated with the nonautomated optimization algorithm.
Collapse
Affiliation(s)
- Fariba Karimi
- Department of Electrical and Computer Engineering, Isfahan University of Technology, Isfahan 8415683111, Iran. These authors have contributed equally to this work as first authors
| | | | | | | |
Collapse
|
134
|
Miterko LN, Baker KB, Beckinghausen J, Bradnam LV, Cheng MY, Cooperrider J, DeLong MR, Gornati SV, Hallett M, Heck DH, Hoebeek FE, Kouzani AZ, Kuo SH, Louis ED, Machado A, Manto M, McCambridge AB, Nitsche MA, Taib NOB, Popa T, Tanaka M, Timmann D, Steinberg GK, Wang EH, Wichmann T, Xie T, Sillitoe RV. Consensus Paper: Experimental Neurostimulation of the Cerebellum. CEREBELLUM (LONDON, ENGLAND) 2019; 18:1064-1097. [PMID: 31165428 PMCID: PMC6867990 DOI: 10.1007/s12311-019-01041-5] [Citation(s) in RCA: 95] [Impact Index Per Article: 19.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
The cerebellum is best known for its role in controlling motor behaviors. However, recent work supports the view that it also influences non-motor behaviors. The contribution of the cerebellum towards different brain functions is underscored by its involvement in a diverse and increasing number of neurological and neuropsychiatric conditions including ataxia, dystonia, essential tremor, Parkinson's disease (PD), epilepsy, stroke, multiple sclerosis, autism spectrum disorders, dyslexia, attention deficit hyperactivity disorder (ADHD), and schizophrenia. Although there are no cures for these conditions, cerebellar stimulation is quickly gaining attention for symptomatic alleviation, as cerebellar circuitry has arisen as a promising target for invasive and non-invasive neuromodulation. This consensus paper brings together experts from the fields of neurophysiology, neurology, and neurosurgery to discuss recent efforts in using the cerebellum as a therapeutic intervention. We report on the most advanced techniques for manipulating cerebellar circuits in humans and animal models and define key hurdles and questions for moving forward.
Collapse
Affiliation(s)
- Lauren N Miterko
- Department of Pathology and Immunology, Department of Neuroscience, Program in Developmental Biology, Baylor College of Medicine, Jan and Dan Duncan Neurological Research Institute of Texas Children's Hospital, 1250 Moursund Street, Suite 1325, Houston, TX, 77030, USA
| | - Kenneth B Baker
- Neurological Institute, Department of Neurosurgery, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA
| | - Jaclyn Beckinghausen
- Department of Pathology and Immunology, Department of Neuroscience, Program in Developmental Biology, Baylor College of Medicine, Jan and Dan Duncan Neurological Research Institute of Texas Children's Hospital, 1250 Moursund Street, Suite 1325, Houston, TX, 77030, USA
| | - Lynley V Bradnam
- Department of Exercise Science, Faculty of Science, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand
| | - Michelle Y Cheng
- Department of Neurosurgery, Stanford University School of Medicine, 1201 Welch Road, MSLS P352, Stanford, CA, 94305-5487, USA
| | - Jessica Cooperrider
- Neurological Institute, Department of Neurosurgery, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA
| | - Mahlon R DeLong
- Department of Neurology, Emory University, Atlanta, GA, 30322, USA
| | - Simona V Gornati
- Department of Neuroscience, Erasmus Medical Center, 3015 AA, Rotterdam, Netherlands
| | - Mark Hallett
- Human Motor Control Section, NINDS, NIH, Building 10, Room 7D37, 10 Center Dr MSC 1428, Bethesda, MD, 20892-1428, USA
| | - Detlef H Heck
- Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, 855 Monroe Ave, Memphis, TN, 38163, USA
| | - Freek E Hoebeek
- Department of Neuroscience, Erasmus Medical Center, 3015 AA, Rotterdam, Netherlands
- NIDOD Department, Wilhelmina Children's Hospital, University Medical Center Utrecht Brain Center, Utrecht, Netherlands
| | - Abbas Z Kouzani
- School of Engineering, Deakin University, Geelong, VIC, 3216, Australia
| | - Sheng-Han Kuo
- Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, 10032, USA
| | - Elan D Louis
- Department of Neurology, Yale School of Medicine, Department of Chronic Disease Epidemiology, Yale School of Public Health, Center for Neuroepidemiology and Clinical Research, Yale School of Medicine, Yale University, New Haven, CT, 06520, USA
| | - Andre Machado
- Neurological Institute, Department of Neurosurgery, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA
| | - Mario Manto
- Service de Neurologie, CHU-Charleroi, 6000, Charleroi, Belgium
- Service des Neurosciences, Université de Mons, 7000, Mons, Belgium
| | - Alana B McCambridge
- Graduate School of Health, Physiotherapy, University of Technology Sydney, PO Box 123, Broadway, Sydney, NSW, 2007, Australia
| | - Michael A Nitsche
- Department of Psychology and Neurosiences, Leibniz Research Centre for Working Environment and Human Factors, Dortmund, Germany
- Department of Neurology, University Medical Hospital Bergmannsheil, Bochum, Germany
| | | | - Traian Popa
- Human Motor Control Section, NINDS, NIH, Building 10, Room 7D37, 10 Center Dr MSC 1428, Bethesda, MD, 20892-1428, USA
- Defitech Chair of Clinical Neuroengineering, Center for Neuroprosthetics (CNP) and Brain Mind Institute (BMI), Ecole Polytechnique Federale de Lausanne (EPFL), Sion, Switzerland
| | - Masaki Tanaka
- Department of Physiology, Hokkaido University School of Medicine, Sapporo, 060-8638, Japan
| | - Dagmar Timmann
- Department of Neurology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
| | - Gary K Steinberg
- Department of Neurosurgery, Stanford University School of Medicine, 1201 Welch Road, MSLS P352, Stanford, CA, 94305-5487, USA
- R281 Department of Neurosurgery, Stanfod University School of Medicine, 300 Pasteur Drive, Stanford, CA, 94305, USA
| | - Eric H Wang
- Department of Neurosurgery, Stanford University School of Medicine, 1201 Welch Road, MSLS P352, Stanford, CA, 94305-5487, USA
| | - Thomas Wichmann
- Department of Neurology, Emory University, Atlanta, GA, 30322, USA
- Yerkes National Primate Research Center, Emory University, Atlanta, GA, 30322, USA
| | - Tao Xie
- Department of Neurology, University of Chicago, 5841 S. Maryland Avenue, MC 2030, Chicago, IL, 60637-1470, USA
| | - Roy V Sillitoe
- Department of Pathology and Immunology, Department of Neuroscience, Program in Developmental Biology, Baylor College of Medicine, Jan and Dan Duncan Neurological Research Institute of Texas Children's Hospital, 1250 Moursund Street, Suite 1325, Houston, TX, 77030, USA.
| |
Collapse
|
135
|
Islam R, Cuellar CA, Felmlee B, Riccelli T, Silvernail J, Boschen SL, Grahn P, Lavrov I. Multifactorial motor behavior assessment for real-time evaluation of emerging therapeutics to treat neurologic impairments. Sci Rep 2019; 9:16503. [PMID: 31712725 PMCID: PMC6848091 DOI: 10.1038/s41598-019-52806-1] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2019] [Accepted: 10/15/2019] [Indexed: 12/31/2022] Open
Abstract
Integrating multiple assessment parameters of motor behavior is critical for understanding neural activity dynamics during motor control in both intact and dysfunctional nervous systems. Here, we described a novel approach (termed Multifactorial Behavioral Assessment (MfBA)) to integrate, in real-time, electrophysiological and biomechanical properties of rodent spinal sensorimotor network activity with behavioral aspects of motor task performance. Specifically, the MfBA simultaneously records limb kinematics, multi-directional forces and electrophysiological metrics, such as high-fidelity chronic intramuscular electromyography synchronized in time to spinal stimulation in order to characterize spinal cord functional motor evoked potentials (fMEPs). Additionally, we designed the MfBA to incorporate a body weight support system to allow bipedal and quadrupedal stepping on a treadmill and in an open field environment to assess function in rodent models of neurologic disorders that impact motor activity. This novel approach was validated using, a neurologically intact cohort, a cohort with unilateral Parkinsonian motor deficits due to midbrain lesioning, and a cohort with complete hind limb paralysis due to T8 spinal cord transection. In the SCI cohort, lumbosacral epidural electrical stimulation (EES) was applied, with and without administration of the serotonergic agonist Quipazine, to enable hind limb motor functions following paralysis. The results presented herein demonstrate the MfBA is capable of integrating multiple metrics of motor activity in order to characterize relationships between EES inputs that modulate mono- and polysynaptic outputs from spinal circuitry which in turn, can be used to elucidate underlying electrophysiologic mechanisms of motor behavior. These results also demonstrate that proposed MfBA is an effective tool to integrate biomechanical and electrophysiology metrics, synchronized to therapeutic inputs such as EES or pharmacology, during body weight supported treadmill or open field motor activities, to target a high range of variations in motor behavior as a result of neurological deficit at the different levels of CNS.
Collapse
Affiliation(s)
- Riazul Islam
- Department of Neurology, Mayo Clinic, Rochester, MN, USA
| | - Carlos A Cuellar
- Centro de Investigación en Ciencias de la Salud (CICSA), Universidad Anáhuac México, Campus Norte, Huixquilucan, State of Mexico, Mexico
| | - Ben Felmlee
- Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA
| | | | | | | | - Peter Grahn
- Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA
- Department of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN, USA
| | - Igor Lavrov
- Department of Neurology, Mayo Clinic, Rochester, MN, USA.
- Department of Neurologic Surgery, Mayo Clinic, Rochester, MN, USA.
- Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
- Department of Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.
| |
Collapse
|
136
|
The Effect of Sertoli Cells on Xenotransplantation and Allotransplantation of Ventral Mesencephalic Tissue in a Rat Model of Parkinson's Disease. Cells 2019; 8:cells8111420. [PMID: 31718058 PMCID: PMC6912403 DOI: 10.3390/cells8111420] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2019] [Revised: 11/06/2019] [Accepted: 11/08/2019] [Indexed: 12/19/2022] Open
Abstract
Intra-striatal transplantation of fetal ventral mesencephalic (VM) tissue has a therapeutic effect on patients with Parkinson’s disease (PD). Sertoli cells (SCs) possess immune-modulatory properties that benefit transplantation. We hypothesized that co-graft of SCs with VM tissue can attenuate rejection. Hemi-parkinsonian rats were generated by injecting 6-hydroxydopamine into the right medial forebrain bundle of Sprague Dawley (SD) rats. The rats were then intrastriatally transplanted with VM tissue from rats or pigs (rVM or pVM), with/without a co-graft of SCs (rVM+SCs or pVM+SCs). Recovery of dopaminergic function and survival of the grafts were evaluated using the apomorphine-induced rotation test and small animal-positron emission tomography (PET) coupled with [18F] DOPA or [18F] FE-PE2I, respectively. Immunohistochemistry (IHC) examination was used to determine the survival of the grafted dopaminergic neurons in the striatum and to investigate immune-modulatory effects of SCs. The results showed that the rVM+SCs and pVM+SCs groups had significantly improved drug-induced rotational behavior compared with the VM alone groups. PET revealed a significant increase in specific uptake ratios (SURs) of [18F] DOPA and [18F] FE-PE2I in the grafted striatum of the rVM+SCs and pVM+SCs groups as compared to that of the rVM and pVM groups. SC and VM tissue co-graft led to better dopaminergic (DA) cell survival. The co-grafted groups exhibited lower populations of T-cells and activated microglia compared to the groups without SCs. Our results suggest that co-graft of SCs benefit both xeno- and allo-transplantation of VM tissue in a PD rat model. Use of SCs enhanced the survival of the grafted dopaminergic neurons and improved functional recovery. The enhancement may in part be attributable to the immune-modulatory properties of SCs. In addition, [18F]DOPA and [18F]FE-PE2I coupled with PET may provide a feasible method for in vivo evaluation of the functional integrity of the grafted DA cell in parkinsonian rats.
Collapse
|
137
|
Jerusalem A, Al-Rekabi Z, Chen H, Ercole A, Malboubi M, Tamayo-Elizalde M, Verhagen L, Contera S. Electrophysiological-mechanical coupling in the neuronal membrane and its role in ultrasound neuromodulation and general anaesthesia. Acta Biomater 2019; 97:116-140. [PMID: 31357005 DOI: 10.1016/j.actbio.2019.07.041] [Citation(s) in RCA: 37] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2019] [Revised: 07/20/2019] [Accepted: 07/23/2019] [Indexed: 01/23/2023]
Abstract
The current understanding of the role of the cell membrane is in a state of flux. Recent experiments show that conventional models, considering only electrophysiological properties of a passive membrane, are incomplete. The neuronal membrane is an active structure with mechanical properties that modulate electrophysiology. Protein transport, lipid bilayer phase, membrane pressure and stiffness can all influence membrane capacitance and action potential propagation. A mounting body of evidence indicates that neuronal mechanics and electrophysiology are coupled, and together shape the membrane potential in tight coordination with other physical properties. In this review, we summarise recent updates concerning electrophysiological-mechanical coupling in neuronal function. In particular, we aim at making the link with two relevant yet often disconnected fields with strong clinical potential: the use of mechanical vibrations-ultrasound-to alter the electrophysiogical state of neurons, e.g., in neuromodulation, and the theories attempting to explain the action of general anaesthetics. STATEMENT OF SIGNIFICANCE: General anaesthetics revolutionised medical practice; now an apparently unrelated technique, ultrasound neuromodulation-aimed at controlling neuronal activity by means of ultrasound-is poised to achieve a similar level of impact. While both technologies are known to alter the electrophysiology of neurons, the way they achieve it is still largely unknown. In this review, we argue that in order to explain their mechanisms/effects, the neuronal membrane must be considered as a coupled mechano-electrophysiological system that consists of multiple physical processes occurring concurrently and collaboratively, as opposed to sequentially and independently. In this framework the behaviour of the cell membrane is not the result of stereotypical mechanisms in isolation but instead emerges from the integrative behaviour of a complexly coupled multiphysics system.
Collapse
Affiliation(s)
- Antoine Jerusalem
- Department of Engineering Science, University of Oxford, Parks Road, Oxford OX1 3PJ, UK.
| | - Zeinab Al-Rekabi
- Department of Physics, University of Oxford, Parks Road, Oxford OX1 3PU, UK
| | - Haoyu Chen
- Department of Engineering Science, University of Oxford, Parks Road, Oxford OX1 3PJ, UK
| | - Ari Ercole
- Division of Anaesthesia, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK
| | - Majid Malboubi
- Department of Engineering Science, University of Oxford, Parks Road, Oxford OX1 3PJ, UK
| | - Miren Tamayo-Elizalde
- Department of Engineering Science, University of Oxford, Parks Road, Oxford OX1 3PJ, UK
| | - Lennart Verhagen
- Wellcome Centre for Integrative Neuroimaging (WIN), Department of Experimental Psychology, University of Oxford, Oxford OX1 3TA, UK; WIN, Centre for Functional MRI of the Brain, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK
| | - Sonia Contera
- Department of Physics, University of Oxford, Parks Road, Oxford OX1 3PU, UK.
| |
Collapse
|
138
|
Patel SR, Lieber CM. Precision electronic medicine in the brain. Nat Biotechnol 2019; 37:1007-1012. [PMID: 31477925 PMCID: PMC6741780 DOI: 10.1038/s41587-019-0234-8] [Citation(s) in RCA: 34] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2018] [Accepted: 07/23/2019] [Indexed: 02/06/2023]
Abstract
Periodically throughout history developments from adjacent fields of science and technology reach a tipping point where together they produce unparalleled advances, such as the Allen Brain Atlas and the Human Genome Project. Today, research focused at the interface between the nervous system and electronics is not only leading to advances in fundamental neuroscience, but also unlocking the potential of implants capable of cellular-level therapeutic targeting. Ultimately, these personalized electronic therapies will provide new treatment modalities for neurodegenerative and neuropsychiatric illness; powerful control of prosthetics for restorative function in degenerative diseases, trauma and amputation; and even augmentation of human cognition. Overall, we believe that emerging advances in tissue-like electronics will enable minimally invasive devices capable of establishing a stable long-term cellular neural interface and providing long-term treatment for chronic neurological conditions.
Collapse
Affiliation(s)
- Shaun R Patel
- McCance Center for Brain Health, Genetics and Aging Research Unit, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
| | - Charles M Lieber
- Department of Chemistry and Chemical Biology, Center for Brain Science, and John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
| |
Collapse
|
139
|
Awakening: Predicting external stimulation to force transitions between different brain states. Proc Natl Acad Sci U S A 2019; 116:18088-18097. [PMID: 31427539 PMCID: PMC6731634 DOI: 10.1073/pnas.1905534116] [Citation(s) in RCA: 116] [Impact Index Per Article: 23.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
We describe a quantitative and robust definition of a brain state as an ensemble of “metastable substates,” each with a probabilistic stability and occurrence frequency. Fitting this to a generative whole-brain model provides an innovative avenue for predicting where simulated brain stimulation can force transitions between different brain states. We provide proof-of-concept by systematically applying this model framework to neuroimaging data of the human sleep cycle and show where to stimulate to awaken the human sleeping brain and vice versa. These results suggest an avenue for using causal whole-brain models to discover in silico where to force a transition between brain states, which may potentially support recovery in disease. A fundamental problem in systems neuroscience is how to force a transition from one brain state to another by external driven stimulation in, for example, wakefulness, sleep, coma, or neuropsychiatric diseases. This requires a quantitative and robust definition of a brain state, which has so far proven elusive. Here, we provide such a definition, which, together with whole-brain modeling, permits the systematic study in silico of how simulated brain stimulation can force transitions between different brain states in humans. Specifically, we use a unique neuroimaging dataset of human sleep to systematically investigate where to stimulate the brain to force an awakening of the human sleeping brain and vice versa. We show where this is possible using a definition of a brain state as an ensemble of “metastable substates,” each with a probabilistic stability and occurrence frequency fitted by a generative whole-brain model, fine-tuned on the basis of the effective connectivity. Given the biophysical limitations of direct electrical stimulation (DES) of microcircuits, this opens exciting possibilities for discovering stimulation targets and selecting connectivity patterns that can ensure propagation of DES-induced neural excitation, potentially making it possible to create awakenings from complex cases of brain injury.
Collapse
|
140
|
Amoozegar S, Pooyan M, Roughani M. Toward a closed-loop deep brain stimulation in Parkinson's disease using local field potential in parkinsonian rat model. Med Hypotheses 2019; 132:109360. [PMID: 31442919 DOI: 10.1016/j.mehy.2019.109360] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2019] [Revised: 08/04/2019] [Accepted: 08/11/2019] [Indexed: 02/06/2023]
Abstract
Deep brain stimulation (DBS) is an invasive method used for treating Parkinson's disease in its advanced stages. Nowadays, the initial adjustment of DBS parameters and their automatic matching proportion to the progression of the disease is viewed as one of the research areas discussed by the researchers, which is called closed-loop DBS. Various studies were conducted regarding finding the signal(s) which reflects different symptoms of the disease. Local Field Potential (LFP) is one of the signals that is suitable for using as feedback, because it can be recorded by the same implemented electrodes for stimulation. The present study aimed to identify the distinguishing features of patients from healthy individuals using LFP signals. METHODS In the present study, LFP was recorded from the rats in sham and parkinsonian model groups. After evaluating the signals in the frequency domain, sixty-six features were extracted from power spectral density of LFPs. The features were classified by Support Vector Machine (SVM) to determine the ability of features for separating parkinsonian rats from healthy ones. Finally, the most effective features were selected for distinguishing between the sham and parkinsonian model groups using a genetic algorithm. RESULTS The results indicated that the frequency domain features of LFP signals from rats have capacity of using them as a feedback for closed-loop DBS. The accuracy of the Support Vector Machine classification using all 66 features was 80.42% which increased to 84.41% using 38 features selected by genetic algorithm. The proposed method not only increase the accuracy, but it also reduce computation by decreasing the number of the effective features. The results indicate the significant capacity of the proposed method for identifying the effective high-frequency features to control the closed-loop DBS. CONCLUSIONS The ability of using LFP signals as feedback in closed-loop DBS was shown by extracting useful information in frequency bands below and above 100 Hz regarding LFP signals of parkinsonian rats and sham ones. Based on the results, features at frequencies above 100 Hz were more powerful and robust than below 100 Hz. The genetic algorithm was used for optimizing the classification problem.
Collapse
Affiliation(s)
- Sana Amoozegar
- Department of Biomedical Engineering, Faculty of Engineering, Shahed University, Tehran, Iran
| | - Mohammad Pooyan
- Department of Biomedical Engineering, Faculty of Engineering, Shahed University, Tehran, Iran.
| | - Mehrdad Roughani
- Department of Physiology, Faculty of Medical Sciences, Shahed University, Tehran, Iran
| |
Collapse
|
141
|
Boutet A, Rashid T, Hancu I, Elias GJB, Gramer RM, Germann J, Dimarzio M, Li B, Paramanandam V, Prasad S, Ranjan M, Coblentz A, Gwun D, Chow CT, Maciel R, Soh D, Fiveland E, Hodaie M, Kalia SK, Fasano A, Kucharczyk W, Pilitsis J, Lozano AM. Functional MRI Safety and Artifacts during Deep Brain Stimulation: Experience in 102 Patients. Radiology 2019; 293:174-183. [PMID: 31385756 DOI: 10.1148/radiol.2019190546] [Citation(s) in RCA: 37] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
BackgroundWith growing numbers of patients receiving deep brain stimulation (DBS), radiologists are encountering these neuromodulation devices at an increasing rate. Current MRI safety guidelines, however, limit MRI access in these patients.PurposeTo describe an MRI (1.5 T and 3 T) experience and safety profile in a large cohort of participants with active DBS systems and characterize the hardware-related artifacts on images from functional MRI.Materials and MethodsIn this prospective study, study participants receiving active DBS underwent 1.5- or 3-T MRI (T1-weighted imaging and gradient-recalled echo [GRE]-echo-planar imaging [EPI]) between June 2017 and October 2018. Short- and long-term adverse events were tracked. The authors quantified DBS hardware-related artifacts on images from GRE-EPI (functional MRI) at the cranial coil wire and electrode contacts. Segmented artifacts were then transformed into standard space to define the brain areas affected by signal loss. Two-sample t tests were used to assess the difference in artifact size between 1.5- and 3-T MRI.ResultsA total of 102 participants (mean age ± standard deviation, 60 years ± 11; 65 men) were evaluated. No MRI-related short- and long-term adverse events or acute changes were observed. DBS artifacts were most prominent near the electrode contacts and over the frontoparietal cortical area where the redundancy of the extension wire is placed subcutaneously. The mean electrode contact artifact diameter was 9.3 mm ± 1.6, and 1.9% ± 0.8 of the brain was obscured by the coil artifact. The coil artifacts were larger at 3 T than at 1.5 T, obscuring 2.1% ± 0.7 and 1.4% ± 0.7 of intracranial volume, respectively (P < .001). The superficial frontoparietal cortex and deep structures neighboring the electrode contacts were most commonly obscured.ConclusionWith a priori local safety testing, patients receiving deep brain stimulation may safely undergo 1.5- and 3-T MRI. Deep brain stimulation hardware-related artifacts only affect a small proportion of the brain.© RSNA, 2019Online supplemental material is available for this article.See also the editorial by Martin in this issue.
Collapse
Affiliation(s)
- Alexandre Boutet
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Tanweer Rashid
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Ileana Hancu
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Gavin J B Elias
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Robert M Gramer
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Jürgen Germann
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Marisa Dimarzio
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Bryan Li
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Vijayashankar Paramanandam
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Sreeram Prasad
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Manish Ranjan
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Ailish Coblentz
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Dave Gwun
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Clement T Chow
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Ricardo Maciel
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Derrick Soh
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Eric Fiveland
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Mojgan Hodaie
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Suneil K Kalia
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Alfonso Fasano
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Walter Kucharczyk
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Julie Pilitsis
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| | - Andres M Lozano
- From the Joint Department of Medical Imaging, University of Toronto, Toronto, Canada (A.B., A.C., W.K.); Division of Neurosurgery, Toronto Western Hospital, University Health Network, 399 Bathurst St, WW 4-437, Toronto, ON, Canada M5T 2S8 (A.B., G.J.B.E., R.M.G., J.G., B.L., V.P., S.P., M.R., A.C., D.G., C.T.C., R.M., D.S., M.H., S.K.K., A.F., W.K., A.M.L.); Department of Neuroscience and Experimental Therapeutics, Albany Medical College, Albany, NY (T.R., M.D., J.P.); Edmond J. Safra Program in Parkinson's Disease, Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada (I.H., V.P., S.P., R.M., D.S., A.F.); GE Global Research Center, Niskayuna, NY (E.F.); Krembil Brain Institute, Toronto, Canada (A.F.); and Department of Neurosurgery, Albany Medical Center, Albany, NY (J.P.)
| |
Collapse
|
142
|
Abstract
To enable patient- and disease-specific diagnostic and treatment at the intracellular level in real time, it is imperative to engineer a perfect way to locally stimulate selected individual neurons, navigate and dispense a cargo of biomolecules into damaged cells or image sites with relatively high efficacy and with adequate spatial and temporal resolutions. Significant progress has been made using biotechnology; especially with the development of bioinformatics, there are endless molecular databases to identify biomolecules to target almost any disease-specific biomarker. Conversely, the technobiology approach that exploits advanced engineering to control underlying molecular mechanisms to recover biosystem's energy states at the molecular level as well as at the level of the entire network of cells (i.e., the internet of the human body) is still in its early research stage. The recently developed magnetoelectric nanoparticles (MENPs) provide a tool to enable the unique capabilities of technobiology. Using exemplary studies that could potentially lead to future pinpoint treatment and prevention of cancer, neurodegenerative diseases, and HIV, this article discusses how MENPs could become a vital enabling tool of technobiology.
Collapse
Affiliation(s)
- Sakhrat Khizroev
- Center for Personalized Nanomedicine, Florida International University, Miami, Florida 33199
| |
Collapse
|
143
|
Vaidya AR, Pujara MS, Petrides M, Murray EA, Fellows LK. Lesion Studies in Contemporary Neuroscience. Trends Cogn Sci 2019; 23:653-671. [PMID: 31279672 PMCID: PMC6712987 DOI: 10.1016/j.tics.2019.05.009] [Citation(s) in RCA: 102] [Impact Index Per Article: 20.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2019] [Revised: 05/22/2019] [Accepted: 05/23/2019] [Indexed: 02/06/2023]
Abstract
Studies of humans with focal brain damage and non-human animals with experimentally induced brain lesions have provided pivotal insights into the neural basis of behavior. As the repertoire of neural manipulation and recording techniques expands, the utility of studying permanent brain lesions bears re-examination. Studies on the effects of permanent lesions provide vital data about brain function that are distinct from those of reversible manipulations. Focusing on work carried out in humans and nonhuman primates, we address the inferential strengths and limitations of lesion studies, recent methodological developments, the integration of this approach with other methods, and the clinical and ecological relevance of this research. We argue that lesion studies are essential to the rigorous assessment of neuroscience theories.
Collapse
Affiliation(s)
- Avinash R Vaidya
- Department of Cognitive, Linguistic, and Psychological Sciences, Carney Institute for Brain Sciences, Brown University, Providence, RI, USA.
| | - Maia S Pujara
- Section on the Neurobiology of Learning and Memory, Laboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
| | - Michael Petrides
- Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada
| | - Elisabeth A Murray
- Section on the Neurobiology of Learning and Memory, Laboratory of Neuropsychology, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA
| | - Lesley K Fellows
- Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada
| |
Collapse
|
144
|
Stimulation of the Posterior Cingulate Cortex Impairs Episodic Memory Encoding. J Neurosci 2019; 39:7173-7182. [PMID: 31358651 DOI: 10.1523/jneurosci.0698-19.2019] [Citation(s) in RCA: 48] [Impact Index Per Article: 9.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2019] [Revised: 05/29/2019] [Accepted: 07/10/2019] [Indexed: 11/21/2022] Open
Abstract
Neuroimaging experiments implicate the posterior cingulate cortex (PCC) in episodic memory processing, making it a potential target for responsive neuromodulation strategies outside of the hippocampal network. However, causal evidence for the role that PCC plays in memory encoding is lacking. In human female and male participants (N = 17) undergoing seizure mapping, we investigated functional properties of the PCC using deep brain stimulation (DBS) and stereotactic electroencephalography. We used a verbal free recall paradigm in which the PCC was stimulated during presentation of half of the study lists, whereas no stimulation was applied during presentation of the remaining lists. We investigated whether stimulation affected memory and modulated hippocampal activity. Results revealed four main findings. First, stimulation during episodic memory encoding impaired subsequent free recall, predominantly for items presented early in the study lists. Second, PCC stimulation increased hippocampal gamma-band power. Third, stimulation-induced hippocampal gamma power predicted the magnitude of memory impairment. Fourth, functional connectivity between the hippocampus and PCC predicted the strength of the stimulation effect on memory. Our findings offer causal evidence implicating the PCC in episodic memory encoding. Importantly, the results indicate that stimulation targeted outside of the temporal lobe can modulate hippocampal activity and impact behavior. Furthermore, measures of connectivity between brain regions within a functional network can be informative in predicting behavioral effects of stimulation. Our findings have significant implications for developing therapies to treat memory disorders and cognitive impairment using DBS.SIGNIFICANCE STATEMENT Cognitive impairment and memory loss are critical public health challenges. Deep brain stimulation (DBS) is a promising tool for developing strategies to ameliorate memory disorders by targeting brain regions involved in mnemonic processing. Using DBS, our study sheds light on the lesser-known role of the posterior cingulate cortex (PCC) in memory encoding. Stimulating the PCC during encoding impairs subsequent recall memory. The degree of impairment is predicted by stimulation-induced hippocampal gamma oscillations and functional connectivity between PCC and hippocampus. Our findings provide the first causal evidence implicating PCC in memory encoding and highlight the PCC as a favorable target for neuromodulation strategies using a priori connectivity measures to predict stimulation effects. This has significant implications for developing therapies for memory diseases.
Collapse
|
145
|
Wang J, Wang H, He T, He B, Thakor NV, Lee C. Investigation of Low-Current Direct Stimulation for Rehabilitation Treatment Related to Muscle Function Loss Using Self-Powered TENG System. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2019; 6:1900149. [PMID: 31380204 PMCID: PMC6662055 DOI: 10.1002/advs.201900149] [Citation(s) in RCA: 44] [Impact Index Per Article: 8.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/20/2019] [Revised: 03/13/2019] [Indexed: 05/19/2023]
Abstract
Muscle function loss is characterized as abnormal or completely lost muscle capabilities, and it can result from neurological disorders or nerve injuries. The currently available clinical treatment is to electrically stimulate the diseased muscles. Here, a self-powered system of a stacked-layer triboelectric nanogenerator (TENG) and a multiple-channel epimysial electrode to directly stimulate muscles is demonstrated. Then, the two challenges regarding direct TENG muscle stimulation are further investigated. For the first challenge of improving low-current TENG stimulation efficiency, it is found that the optimum stimulation efficiency can be achieved by conducting a systematic mapping with a multiple-channel epimysial electrode. The second challenge is TENG stimulation stability. It is found that the force output generated by TENGs is more stable than using the conventional square wave stimulation and enveloped high frequency stimulation. With modelling and in vivo measurements, it is confirmed that the two factors that account for the stable stimulation using TENGs are the long pulse duration and low current amplitude. The current waveform of TENGs can effectively avoid synchronous motoneuron recruitment at the two stimulation electrodes to reduce force fluctuation. Here, after investigating these two challenges, it is believed that TENG direct muscle stimulation could be used for rehabilitative and therapeutic purpose of muscle function loss treatment.
Collapse
Affiliation(s)
- Jiahui Wang
- Department of Electrical and Computer EngineeringNational University of Singapore4 Engineering Drive 3117576Singapore
- Singapore Institute for Neurotechnology (SINAPSE)National University of Singapore28 Medical Drive, #05‐COR117456Singapore
- Hybrid‐Integrated Flexible (Stretchable) Electronic Systems ProgramNational University of Singapore5 Engineering Drive 1117608Singapore
| | - Hao Wang
- Department of Electrical and Computer EngineeringNational University of Singapore4 Engineering Drive 3117576Singapore
- Hybrid‐Integrated Flexible (Stretchable) Electronic Systems ProgramNational University of Singapore5 Engineering Drive 1117608Singapore
| | - Tianyiyi He
- Department of Electrical and Computer EngineeringNational University of Singapore4 Engineering Drive 3117576Singapore
- Hybrid‐Integrated Flexible (Stretchable) Electronic Systems ProgramNational University of Singapore5 Engineering Drive 1117608Singapore
- NUS Suzhou Research Institute (NUSRI)SuzhouIndustrial Park, Suzhou215123P. R. China
| | - Borong He
- Department of Electrical and Computer EngineeringNational University of Singapore4 Engineering Drive 3117576Singapore
- Hybrid‐Integrated Flexible (Stretchable) Electronic Systems ProgramNational University of Singapore5 Engineering Drive 1117608Singapore
| | - Nitish V. Thakor
- Department of Electrical and Computer EngineeringNational University of Singapore4 Engineering Drive 3117576Singapore
- Singapore Institute for Neurotechnology (SINAPSE)National University of Singapore28 Medical Drive, #05‐COR117456Singapore
- Hybrid‐Integrated Flexible (Stretchable) Electronic Systems ProgramNational University of Singapore5 Engineering Drive 1117608Singapore
| | - Chengkuo Lee
- Department of Electrical and Computer EngineeringNational University of Singapore4 Engineering Drive 3117576Singapore
- Singapore Institute for Neurotechnology (SINAPSE)National University of Singapore28 Medical Drive, #05‐COR117456Singapore
- Hybrid‐Integrated Flexible (Stretchable) Electronic Systems ProgramNational University of Singapore5 Engineering Drive 1117608Singapore
- NUS Suzhou Research Institute (NUSRI)SuzhouIndustrial Park, Suzhou215123P. R. China
| |
Collapse
|
146
|
Reyes-Garcés N, Diwan M, Boyacı E, Gómez-Ríos GA, Bojko B, Nobrega JN, Bambico FR, Hamani C, Pawliszyn J. In Vivo Brain Sampling Using a Microextraction Probe Reveals Metabolic Changes in Rodents after Deep Brain Stimulation. Anal Chem 2019; 91:9875-9884. [DOI: 10.1021/acs.analchem.9b01540] [Citation(s) in RCA: 37] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Nathaly Reyes-Garcés
- Department of Chemistry, University of Waterloo, Waterloo, Ontario, Canada N2L 3G1
| | - Mustansir Diwan
- Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario Canada
| | - Ezel Boyacı
- Department of Chemistry, University of Waterloo, Waterloo, Ontario, Canada N2L 3G1
| | - German A. Gómez-Ríos
- Department of Chemistry, University of Waterloo, Waterloo, Ontario, Canada N2L 3G1
| | - Barbara Bojko
- Department of Chemistry, University of Waterloo, Waterloo, Ontario, Canada N2L 3G1
| | - José N. Nobrega
- Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario Canada
| | - Francis R. Bambico
- Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario Canada
| | - Clement Hamani
- Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario Canada
| | - Janusz Pawliszyn
- Department of Chemistry, University of Waterloo, Waterloo, Ontario, Canada N2L 3G1
| |
Collapse
|
147
|
Ibrahim C, Rubin-Kahana DS, Pushparaj A, Musiol M, Blumberger DM, Daskalakis ZJ, Zangen A, Le Foll B. The Insula: A Brain Stimulation Target for the Treatment of Addiction. Front Pharmacol 2019; 10:720. [PMID: 31312138 PMCID: PMC6614510 DOI: 10.3389/fphar.2019.00720] [Citation(s) in RCA: 68] [Impact Index Per Article: 13.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2019] [Accepted: 06/05/2019] [Indexed: 12/15/2022] Open
Abstract
Substance use disorders (SUDs) are a growing public health concern with only a limited number of approved treatments. However, even approved treatments are subject to limited efficacy with high long-term relapse rates. Current treatment approaches are typically a combination of pharmacotherapies and behavioral counselling. Growing evidence and technological advances suggest the potential of brain stimulation techniques for the treatment of SUDs. There are three main brain stimulation techniques that are outlined in this review: transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), and deep brain stimulation (DBS). The insula, a region of the cerebral cortex, is known to be involved in critical aspects underlying SUDs, such as interoception, decision making, anxiety, pain perception, cognition, mood, threat recognition, and conscious urges. This review focuses on both the preclinical and clinical evidence demonstrating the role of the insula in addiction, thereby demonstrating its promise as a target for brain stimulation. Future research should evaluate the optimal parameters for brain stimulation of the insula, through the use of relevant biomarkers and clinical outcomes for SUDs.
Collapse
Affiliation(s)
- Christine Ibrahim
- Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, ON, Canada
- Department of Pharmacology, University of Toronto, Toronto, ON, Canada
| | - Dafna S. Rubin-Kahana
- Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, ON, Canada
- Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, ON, Canada
| | - Abhiram Pushparaj
- Qunuba Sciences, Toronto, ON, Canada
- Ironstone Product Development, Toronto, ON, Canada
| | | | - Daniel M. Blumberger
- Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, ON, Canada
- Temerty Centre for Therapeutic Brain Intervention, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada
| | - Zafiris J. Daskalakis
- Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, ON, Canada
- Temerty Centre for Therapeutic Brain Intervention, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada
| | - Abraham Zangen
- Department of Life Sciences and the Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev, Beer-Sheva, Israel
| | - Bernard Le Foll
- Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, ON, Canada
- Department of Pharmacology, University of Toronto, Toronto, ON, Canada
- Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, ON, Canada
- Addictions Division, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada
- Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada
- Alcohol Research and Treatment Clinic, Centre for Addiction and Mental Health, Toronto, ON, Canada
- Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada
| |
Collapse
|
148
|
Fattahi M, Ashabi G, Karimian SM, Riahi E. Preventing morphine reinforcement with high-frequency deep brain stimulation of the lateral hypothalamic area. Addict Biol 2019; 24:685-695. [PMID: 29737638 DOI: 10.1111/adb.12634] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2017] [Revised: 03/03/2018] [Accepted: 04/17/2018] [Indexed: 12/31/2022]
Abstract
Deep brain stimulation (DBS) has been proposed as a promising intervention for patients with treatment-refractory substance use disorder. Here, we investigated if high-frequency DBS in the lateral hypothalamic area (LHA) could affect drug-induced reinforcement. Rats were bilaterally implanted with bipolar stimulation electrodes in the LHA and trained to the morphine conditioned place preference. DBS (monophasic square pulses, 130 Hz, 100-microsecond pulse duration and 150 μA) was applied during the morphine-pairing trials (30 minutes daily for 4 days) or drug-free postconditioning test (15 minutes) to determine its effect on the acquisition or expression of morphine reward, respectively. LHA DBS during morphine-conditioning trials blocked subsequent preference for the drug-associated context. In contrast, DBS in the postconditioning phase failed to inhibit expression of morphine-induced conditioned place preference. These results were further controlled by ruling out significant changes by DBS in physical performance and anxiety-like behavior as measured by an open field test and by precluding anhedonia-like behavior as measured by sucrose consumption test. Our results suggest that LHA DBS can prevent development of morphine reward without diminishing the motivation for naturally rewarding stimuli. Therefore, the LHA could be a potential target for research in the field of DBS-based treatment of intractable substance use disorder. Further studies will be necessary to assess the translatability of these findings to the clinic.
Collapse
Affiliation(s)
- Mojdeh Fattahi
- Department of Physiology, School of MedicineTehran University of Medical Sciences Tehran Iran
| | - Ghorbangol Ashabi
- Department of Physiology, School of MedicineTehran University of Medical Sciences Tehran Iran
| | - Seyed Morteza Karimian
- Department of Physiology, School of MedicineTehran University of Medical Sciences Tehran Iran
| | - Esmail Riahi
- Department of Physiology, School of MedicineTehran University of Medical Sciences Tehran Iran
| |
Collapse
|
149
|
Cha GD, Kang D, Lee J, Kim D. Bioresorbable Electronic Implants: History, Materials, Fabrication, Devices, and Clinical Applications. Adv Healthc Mater 2019; 8:e1801660. [PMID: 30957984 DOI: 10.1002/adhm.201801660] [Citation(s) in RCA: 57] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2018] [Revised: 02/14/2019] [Indexed: 12/13/2022]
Abstract
Medical implants, either passive implants for structural support or implantable devices with active electronics, have been widely used for the diagnosis and treatment of various diseases and clinical issues. These implants offer various functions, including mechanical support of biological structures in orthopedic and dental applications, continuous electrophysiological monitoring and feedback of electrical stimulation in neuronal and cardiac applications, and controlled drug delivery while maintaining arterial structure in drug-eluting stents. Although these implants exhibit long-term biocompatibility, surgery for their retrieval is often required, which imposes physical, biological, and economical burdens on the patients. Therefore, as an alternative to such secondary surgeries, bioresorbable implants that disappear after a certain period of time inside the body, including bioresorbable active electronics, have been highlighted recently. This review first discusses the historical background of medical implants and briefly define related terminology. Representative examples of non-degradable medical implants for passive structural support and/or for diagnosis and therapy with active electronics are also provided. Then, recent progress in bioresorbable active implants composed of biosignal sensors, actuators for therapeutics, wireless power supply components, and their integrated systems are reviewed. Finally, clinical applications of these bioresorbable electronic implants are exemplified with brief conclusion and future outlook.
Collapse
Affiliation(s)
- Gi Doo Cha
- Center for Nanoparticle ResearchInstitute for Basic Science (IBS) Seoul 08826 Republic of Korea
- School of Chemical and Biological EngineeringInstitute of Chemical ProcessesSeoul National University (SNU) Seoul 08826 Republic of Korea
| | - Dayoung Kang
- Center for Nanoparticle ResearchInstitute for Basic Science (IBS) Seoul 08826 Republic of Korea
- School of Chemical and Biological EngineeringInstitute of Chemical ProcessesSeoul National University (SNU) Seoul 08826 Republic of Korea
| | - Jongha Lee
- Center for Nanoparticle ResearchInstitute for Basic Science (IBS) Seoul 08826 Republic of Korea
- School of Chemical and Biological EngineeringInstitute of Chemical ProcessesSeoul National University (SNU) Seoul 08826 Republic of Korea
| | - Dae‐Hyeong Kim
- Center for Nanoparticle ResearchInstitute for Basic Science (IBS) Seoul 08826 Republic of Korea
- School of Chemical and Biological EngineeringInstitute of Chemical ProcessesSeoul National University (SNU) Seoul 08826 Republic of Korea
| |
Collapse
|
150
|
Lee M, Shim HJ, Choi C, Kim DH. Soft High-Resolution Neural Interfacing Probes: Materials and Design Approaches. NANO LETTERS 2019; 19:2741-2749. [PMID: 31002760 DOI: 10.1021/acs.nanolett.8b04895] [Citation(s) in RCA: 36] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Neural interfacing probes are located between the nervous system and the implanted electronic device in order to acquire information on the complex neuronal activity and to reconstruct impaired neural connectivity. Despite remarkable advancement in recent years, conventional neural interfacing is still unable to completely accomplish these goals, especially in long-term brain interfacing. The major limitation arises from physical and mechanical differences between neural interfacing probes and neural tissues that cause local immune responses and production of scar cells near the interface. Therefore, neural interfaces should ideally be extremely soft and have the physical scale of cells to mitigate the boundary between biotic and abiotic systems. Soft materials for neural interfaces have been intensively investigated to improve both interfacing and long-term signal transmission. The design and fabrication of micro and nanoscale devices have drastically decreased the stiffness of probes and enabled single-neuron measurement. In this Mini Review, we discuss materials and design approaches for developing soft high-resolution neural probes intended for long-term brain interfacing and outline existent challenges for achieving next-generation neural interfacing probes.
Collapse
Affiliation(s)
- Mincheol Lee
- Center for Nanoparticle Research , Institute for Basic Science (IBS) , Seoul 08826 , Republic of Korea
- School of Chemical and Biological Engineering, Institute of Chemical Processes , Seoul National University , Seoul 08826 , Republic of Korea
| | - Hyung Joon Shim
- Center for Nanoparticle Research , Institute for Basic Science (IBS) , Seoul 08826 , Republic of Korea
- School of Chemical and Biological Engineering, Institute of Chemical Processes , Seoul National University , Seoul 08826 , Republic of Korea
| | - Changsoon Choi
- Center for Nanoparticle Research , Institute for Basic Science (IBS) , Seoul 08826 , Republic of Korea
- School of Chemical and Biological Engineering, Institute of Chemical Processes , Seoul National University , Seoul 08826 , Republic of Korea
| | - Dae-Hyeong Kim
- Center for Nanoparticle Research , Institute for Basic Science (IBS) , Seoul 08826 , Republic of Korea
- School of Chemical and Biological Engineering, Institute of Chemical Processes , Seoul National University , Seoul 08826 , Republic of Korea
| |
Collapse
|